1
|
Shimizu T, Maeda S, Link J, Deranteriassian A, Premji A, Verma A, Chervu N, Park J, Girgis M, Benharash P, Hines J, Wainberg Z, Wolfgang C, Burns W, Yu J, Fernandez-Del Castillo C, Lillemoe K, Ferrone C, Donahue T. Clinical and pathological factors associated with survival in patients with pancreatic cancer who receive adjuvant therapy after neoadjuvant therapy: A retrospective multi-institutional analysis. Surgery 2024; 175:1377-1385. [PMID: 38365548 DOI: 10.1016/j.surg.2024.01.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2023] [Revised: 12/29/2023] [Accepted: 01/08/2024] [Indexed: 02/18/2024]
Abstract
BACKGROUND Neoadjuvant therapy is being increasingly used for patients with pancreatic cancer. The role of adjuvant therapy in these patients is unclear. The purpose of this study was to identify clinical and pathologic characteristics that are associated with longer overall survival in patients with pancreatic cancer who receive adjuvant therapy after neoadjuvant therapy. METHODS This study was conducted using multi-institutional data. All patients underwent surgery after at least 1 cycle of neoadjuvant therapy for pancreatic cancer. Patients who died within 3 months after surgery and were known to have distant metastasis or macroscopic residual disease were excluded. Mann-Whitney U test, χ2 analysis, Kaplan-Meier plot, and univariate and multivariate Cox regression analysis were performed as statistical analyses. RESULTS In the present study, 529 patients with resected pancreatic cancer after neoadjuvant therapy were reviewed. For neoadjuvant therapy, 177 (33.5%) patients received neoadjuvant chemotherapy, and 352 (66.5%) patients received neoadjuvant chemoradiotherapy. The median duration of neoadjuvant therapy was 7.0 months (interquartile range, 5.0-8.7). Patients were followed for a median of 23.0 months after surgery. Adjuvant therapy was administered to 297 (56.1%) patients and was not associated with longer overall survival for the entire cohort (24 vs 22 months, P = .31). Interaction analysis showed that adjuvant therapy was associated with longer overall survival in patients who received less than 4 months neoadjuvant therapy (hazard ratio 0.40; 95% confidence interval 0.17-0.95; P = .03) or who had microscopic margin positive surgical resections (hazard ratio 0.56; 95% confidence interval 0.33-0.93; P = .03). CONCLUSION In this retrospective study, there was a survival benefit associated with adjuvant therapy for patients who received less than 4 months of neoadjuvant therapy or had microscopic positive margins.
Collapse
Affiliation(s)
- Takayuki Shimizu
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Shimpei Maeda
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Jason Link
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | | | - Alykhan Premji
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Arjun Verma
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Nikhil Chervu
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Joon Park
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Mark Girgis
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Peyman Benharash
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Joe Hines
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Zev Wainberg
- Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Christopher Wolfgang
- Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD
| | - William Burns
- Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD
| | - Jun Yu
- Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD
| | | | - Keith Lillemoe
- Department of Surgery, Massachusetts General Hospital, Boston, MA
| | - Cristina Ferrone
- Department of Surgery, Massachusetts General Hospital, Boston, MA
| | - Timothy Donahue
- Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA.
| |
Collapse
|
2
|
Labora A, Lee H, Chan C, Tabornal E, Le T, Rashid K, Abt E, Yamao T, Mandl H, Creech A, Premji A, Li L, Link J, Wu N, Radu C, Donahue T. Generation of liver metastases in a mouse model using ultrasound-guided intravenous injection. STAR Protoc 2023; 4:102163. [PMID: 36930646 PMCID: PMC10036864 DOI: 10.1016/j.xpro.2023.102163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2023] [Revised: 01/25/2023] [Accepted: 02/15/2023] [Indexed: 03/18/2023] Open
Abstract
Here, we present a protocol to generate a murine model of liver metastasis by directly injecting tumor cells into the portal vein under ultrasound guidance. We describe steps for animal and cell preparation and two techniques for injecting tumor cells. One technique is freehand, while the other technique is device-assisted using a 3D-printed prototype device. Finally, we describe tumor surveillance with bioluminescent imaging.
Collapse
Affiliation(s)
- Amanda Labora
- Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095, USA.
| | - Hailey Lee
- Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Charlotte Chan
- Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Erin Tabornal
- Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Thuc Le
- Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Khalid Rashid
- Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Evan Abt
- Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Takanobu Yamao
- Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Hanna Mandl
- Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Amanda Creech
- Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Alykhan Premji
- Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Luyi Li
- Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Jason Link
- Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Nanping Wu
- Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Caius Radu
- Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - Timothy Donahue
- Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095, USA.
| |
Collapse
|
3
|
Eng J, Link J, Pelz C, Sears R. Abstract PR010: Multiplex imaging reveals features of organotropism in pancreatic ductal adenocarcinoma. Cancer Res 2023. [DOI: 10.1158/1538-7445.metastasis22-pr010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Abstract
PDAC patients have a dismal prognosis with an 11% 5-year survival rate, driven in part by the fact that 90% of patients are diagnosed with metastatic disease. In a cohort of 300 PDAC patients, we observed that patients who had lung-only metastasis had longer overall survival than the majority of patients with metastasis to the liver. We used gene expression data to develop a signature based on gene expression in primary tumors of liver versus lung organotropism, which we called pORG. Our pORG signature predicts long term survival in PDAC patients and reveals unique features of the primary tumor, including increased interferon and immune activity in lung tropic tumors and increased proliferation and replication stress in liver-tropic tumors. To validate our findings, we generated cyclic immunofluorescence multiplex imaging data for a subset of 34 patients. Single cell image analysis revealed B and T cell infiltration and spatial clustering in low pORG/ lung tropic tumors, and markers of replication stress in high pORG patients. Our work suggests unique targetable tumor and microenvironment features linked to organotropism in PDAC.
Citation Format: Jennifer Eng, Jason Link, Carl Pelz, Rosalie Sears. Multiplex imaging reveals features of organotropism in pancreatic ductal adenocarcinoma [abstract]. In: Proceedings of the AACR Special Conference: Cancer Metastasis; 2022 Nov 14-17; Portland, OR. Philadelphia (PA): AACR; Cancer Res 2022;83(2 Suppl_2):Abstract nr PR010.
Collapse
|
4
|
Pott U, Crasselt C, Fobbe N, Haist M, Heinemann M, Hellmann S, Ivanov D, Jakob C, Jansen D, Lei L, Li R, Link J, Lowke D, Mechtcherine V, Neubauer J, Nicia D, Plank J, Reißig S, Schäfer T, Schilde C, Schmidt W, Schröfl C, Sowoidnich T, Strybny B, Ukrainczyk N, Wolf J, Xiao P, Stephan D. Characterization data of reference materials used for phase II of the priority program DFG SPP 2005 "Opus Fluidum Futurum - Rheology of reactive, multiscale, multiphase construction materials". Data Brief 2023; 47:108902. [PMID: 36747980 PMCID: PMC9898608 DOI: 10.1016/j.dib.2023.108902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2022] [Revised: 01/08/2023] [Accepted: 01/09/2023] [Indexed: 01/15/2023] Open
Abstract
A thorough characterization of base materials is the prerequisite for further research. In this paper, the characterization data of the reference materials (CEM I 42.5 R, limestone powder, calcined clay and a mixture of these three components) used in the second funding phase of the priority program 2005 of the German Research Foundation (DFG SPP 2005) are presented under the aspects of chemical and mineralogical composition as well as physical and chemical properties. The data were collected based on tests performed by up to eleven research groups involved in this cooperative program.
Collapse
Affiliation(s)
- U. Pott
- Department of Civil Engineering, Technische Universität Berlin, Berlin 13355, Germany
| | - C. Crasselt
- Bundesanstalt für Materialforschung und -prüfung, Berlin 12205, Germany
| | - N. Fobbe
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen 91054, Germany
| | - M. Haist
- Institute of Building Materials Science, Leibniz Universität Hannover, Hannover 30167, Germany
| | - M. Heinemann
- F. A. Finger-Institute for Building Material Science, Bauhaus-Universität Weimar, Weimar 99423, Germany
| | - S. Hellmann
- Institute of Geosciences, Applied Geology, Friedrich-Schiller-Universität Jena, Jena 07749, Germany
| | - D. Ivanov
- Institute for Particle Technology (iPAT), Technische Universität Braunschweig, Braunschweig 38106, Germany
| | - C. Jakob
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen 91054, Germany
| | - D. Jansen
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen 91054, Germany
| | - L. Lei
- Department of Chemistry, Technische Universität München, Garching 85748, Germany
| | - R. Li
- Department of Chemistry, Technische Universität München, Garching 85748, Germany
| | - J. Link
- Institute of Building Materials Science, Leibniz Universität Hannover, Hannover 30167, Germany
| | - D. Lowke
- Institute of Building Materials, Concrete Construction and Fire Safety (iBMB), Technische Universität Braunschweig, Braunschweig 38106, Germany
| | - V. Mechtcherine
- Institute of Construction Materials, Technische Universität Dresden, Dresden 01062, Germany
| | - J. Neubauer
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen 91054, Germany
| | - D. Nicia
- Institute of Building Materials, Concrete Construction and Fire Safety (iBMB), Technische Universität Braunschweig, Braunschweig 38106, Germany
| | - J. Plank
- Department of Chemistry, Technische Universität München, Garching 85748, Germany
| | - S. Reißig
- Institute of Construction Materials, Technische Universität Dresden, Dresden 01062, Germany
| | - T. Schäfer
- Institute of Geosciences, Applied Geology, Friedrich-Schiller-Universität Jena, Jena 07749, Germany
| | - C. Schilde
- Institute for Particle Technology (iPAT), Technische Universität Braunschweig, Braunschweig 38106, Germany
| | - W. Schmidt
- Bundesanstalt für Materialforschung und -prüfung, Berlin 12205, Germany
| | - C. Schröfl
- Institute of Construction Materials, Technische Universität Dresden, Dresden 01062, Germany
| | - T. Sowoidnich
- F. A. Finger-Institute for Building Material Science, Bauhaus-Universität Weimar, Weimar 99423, Germany
| | - B. Strybny
- Institute of Building Materials Science, Leibniz Universität Hannover, Hannover 30167, Germany
| | - N. Ukrainczyk
- Construction and Building Materials, Technische Universität Darmstadt, Darmstadt 64287, Germany
| | - J. Wolf
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen 91054, Germany
| | - P. Xiao
- Construction and Building Materials, Technische Universität Darmstadt, Darmstadt 64287, Germany
| | - D. Stephan
- Department of Civil Engineering, Technische Universität Berlin, Berlin 13355, Germany,Corresponding author.
| |
Collapse
|
5
|
Mulqueen RM, Pokholok D, O’Connell BL, Thornton CA, Zhang F, O’Roak BJ, Link J, Yardımcı GG, Sears RC, Steemers FJ, Adey AC. High-content single-cell combinatorial indexing. Nat Biotechnol 2021; 39:1574-1580. [PMID: 34226710 PMCID: PMC8678206 DOI: 10.1038/s41587-021-00962-z] [Citation(s) in RCA: 30] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Accepted: 05/20/2021] [Indexed: 02/06/2023]
Abstract
Single-cell combinatorial indexing (sci) with transposase-based library construction increases the throughput of single-cell genomics assays but produces sparse coverage in terms of usable reads per cell. We develop symmetrical strand sci ('s3'), a uracil-based adapter switching approach that improves the rate of conversion of source DNA into viable sequencing library fragments following tagmentation. We apply this chemistry to assay chromatin accessibility (s3-assay for transposase-accessible chromatin, s3-ATAC) in human cortical and mouse whole-brain tissues, with mouse datasets demonstrating a six- to 13-fold improvement in usable reads per cell compared with other available methods. Application of s3 to single-cell whole-genome sequencing (s3-WGS) and to whole-genome plus chromatin conformation (s3-GCC) yields 148- and 14.8-fold improvements, respectively, in usable reads per cell compared with sci-DNA-sequencing and sci-HiC. We show that s3-WGS and s3-GCC resolve subclonal genomic alterations in patient-derived pancreatic cancer cell lines. We expect that the s3 platform will be compatible with other transposase-based techniques, including sci-MET or CUT&Tag.
Collapse
Affiliation(s)
- Ryan M. Mulqueen
- Oregon Health & Science University, Department of Molecular and Medical Genetics, Portland, OR
| | | | - Brendan L. O’Connell
- Oregon Health & Science University, Department of Molecular and Medical Genetics, Portland, OR
| | - Casey A. Thornton
- Oregon Health & Science University, Department of Molecular and Medical Genetics, Portland, OR
| | | | - Brian J. O’Roak
- Oregon Health & Science University, Department of Molecular and Medical Genetics, Portland, OR
| | - Jason Link
- Oregon Health & Science University, Department of Molecular and Medical Genetics, Portland, OR,Oregon Health & Science University, Knight Cancer Institute, Portland, OR,Oregon Health & Science University, Brendan Colson Center for Pancreatic Care, Portland, OR
| | - Galip Gürkan Yardımcı
- Oregon Health & Science University, Knight Cancer Institute, Portland, OR,Oregon Health & Science University, Cancer Early Detection Advanced Research Center, Portland, OR
| | - Rosalie C. Sears
- Oregon Health & Science University, Department of Molecular and Medical Genetics, Portland, OR,Oregon Health & Science University, Knight Cancer Institute, Portland, OR,Oregon Health & Science University, Brendan Colson Center for Pancreatic Care, Portland, OR,Oregon Health & Science University, Cancer Early Detection Advanced Research Center, Portland, OR
| | | | - Andrew C. Adey
- Oregon Health & Science University, Department of Molecular and Medical Genetics, Portland, OR,Oregon Health & Science University, Knight Cancer Institute, Portland, OR,Oregon Health & Science University, Cancer Early Detection Advanced Research Center, Portland, OR,Oregon Health & Science University, Department of Oncological Sciences, Portland, OR,Oregon Health & Science University, Knight Cardiovascular Institute, Portland, OR,Correspondence to
| |
Collapse
|
6
|
Gil-Díaz T, Jara-Heredia D, Heberling F, Lützenkirchen J, Link J, Sowoidnich T, Ludwig HM, Haist M, Schäfer T. Charge regulated solid-liquid interfaces interacting on the nanoscale: Benchmarking of a generalized speciation code (SINFONIA). Adv Colloid Interface Sci 2021; 294:102469. [PMID: 34252719 DOI: 10.1016/j.cis.2021.102469] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Revised: 06/01/2021] [Accepted: 06/17/2021] [Indexed: 01/07/2023]
Abstract
Surface chemistry of mineral phases in aqueous environments generates the electrostatic forces involved in particle-particle interactions. However, few models directly take into account the influence of surface speciation and changes in solution speciation when the diffuse layer potential profiles of approaching particles overlap and affect each other. These electrostatic interactions can be quantified, ideally, through charge regulation, considering solution and surface speciation changes upon particle approach by coupling state-of-the-art surface complexation models for the two particle surfaces with a Poisson-Boltzmann type distribution of electrostatic potential and ions in the inter-particle space. These models greatly improve the accuracy of inter-particle force calculations at small inter-particle separations compared to constant charge and constant potential approaches. This work aims at advancing charge regulation calculations by including full chemical speciation and advanced surface complexation models (Basic Stern-, three-, or four plane models and charge distribution concepts), for cases of similar and dissimilar surfaces involving the numerical solution of the Poisson-Boltzmann equation for arbitrary electrolytes. The concept was implemented as a Python-based code and in COMSOL. The flexibility and precision of both, concept and implementations are demonstrated in several benchmark calculations testing the new codes against published results or simulations using established speciation codes, including aqueous speciation, surface complexation and various interaction force examples. Due to the flexibility in terms of aqueous chemistry and surface complexation models for various geometries, a large variety of potential applications can be tackled with the developed codes including industrial, biological, and environmental systems, from colloidal suspensions to gas bubbles, emulsions, slurries like cement paste, as well as new possibilities to assess the chemistry in nano-confined systems.
Collapse
|
7
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, Ebisawa K, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Link J, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, de Nolfo GA, Okuno S, Ormes JF, Ospina N, Ozawa S, Pacini L, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Spillantini P, Stolzi F, Sugita S, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K. Measurement of the Iron Spectrum in Cosmic Rays from 10 GeV/n to 2.0 TeV/n with the Calorimetric Electron Telescope on the International Space Station. Phys Rev Lett 2021; 126:241101. [PMID: 34213922 DOI: 10.1103/physrevlett.126.241101] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/15/2021] [Revised: 02/24/2021] [Accepted: 04/12/2021] [Indexed: 06/13/2023]
Abstract
The Calorimetric Electron Telescope (CALET), in operation on the International Space Station since 2015, collected a large sample of cosmic-ray iron over a wide energy interval. In this Letter a measurement of the iron spectrum is presented in the range of kinetic energy per nucleon from 10 GeV/n to 2.0 TeV/n allowing the inclusion of iron in the list of elements studied with unprecedented precision by space-borne instruments. The measurement is based on observations carried out from January 2016 to May 2020. The CALET instrument can identify individual nuclear species via a measurement of their electric charge with a dynamic range extending far beyond iron (up to atomic number Z=40). The energy is measured by a homogeneous calorimeter with a total equivalent thickness of 1.2 proton interaction lengths preceded by a thin (3 radiation lengths) imaging section providing tracking and energy sampling. The analysis of the data and the detailed assessment of systematic uncertainties are described and results are compared with the findings of previous experiments. The observed differential spectrum is consistent within the errors with previous experiments. In the region from 50 GeV/n to 2 TeV/n our present data are compatible with a single power law with spectral index -2.60±0.03.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - Y Akaike
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - E Berti
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - M Bongi
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - N Cannady
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - C Checchia
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Gonzi
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwakecho, Sakyo, Kyoto 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - J Kataoka
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Hakubi Center, Kyoto University, Yoshida Honmachi, Sakyo-ku, Kyoto 606-8501, Japan
- Department of Astronomy, Graduate School of Science, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Kobayashi
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J Link
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology, Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508, Japan
| | - A A Moiseev
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - H M Motz
- Faculty of Science and Engineering, Global Center for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - S Nakahira
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Avenue, Denver, Colorado 80208-6900, USA
| | - N Ospina
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - S Ozawa
- Quantum ICT Advanced Development Center, National Institute of Information and Communications Technology, 4-2-1 Nukui-Kitamachi, Koganei, Tokyo 184-8795, Japan
| | - L Pacini
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - P Papini
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - K Sakai
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - P Spillantini
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - S Sugita
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
| | - Y Tsunesada
- Division of Mathematics and Physics, Graduate School of Science, Osaka City University, 3-3-138 Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - E Vannuccini
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| |
Collapse
|
8
|
Liudahl SM, Betts CB, Sivagnanam S, Morales-Oyarvide V, da Silva A, Yuan C, Hwang S, Grossblatt-Wait A, Leis KR, Larson W, Lavoie MB, Robinson P, Dias Costa A, Väyrynen SA, Clancy TE, Rubinson DA, Link J, Keith D, Horton W, Tempero MA, Vonderheide RH, Jaffee EM, Sheppard B, Goecks J, Sears RC, Park BS, Mori M, Nowak JA, Wolpin BM, Coussens LM. Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome. Cancer Discov 2021; 11:2014-2031. [PMID: 33727309 DOI: 10.1158/2159-8290.cd-20-0841] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2020] [Revised: 12/14/2020] [Accepted: 03/11/2021] [Indexed: 12/12/2022]
Abstract
Immunotherapies targeting aspects of T cell functionality are efficacious in many solid tumors, but pancreatic ductal adenocarcinoma (PDAC) remains refractory to these treatments. Deeper understanding of the PDAC immune ecosystem is needed to identify additional therapeutic targets and predictive biomarkers for therapeutic response and resistance monitoring. To address these needs, we quantitatively evaluated leukocyte contexture in 135 human PDACs at single-cell resolution by profiling density and spatial distribution of myeloid and lymphoid cells within histopathologically defined regions of surgical resections from treatment-naive and presurgically (neoadjuvant)-treated patients and biopsy specimens from metastatic PDAC. Resultant data establish an immune atlas of PDAC heterogeneity, identify leukocyte features correlating with clinical outcomes, and, through an in silico study, provide guidance for use of PDAC tissue microarrays to optimally measure intratumoral immune heterogeneity. Atlas data have direct applicability as a reference for evaluating immune responses to investigational neoadjuvant PDAC therapeutics where pretherapy baseline specimens are not available. SIGNIFICANCE: We provide a phenotypic and spatial immune atlas of human PDAC identifying leukocyte composition at steady state and following standard neoadjuvant therapies. These data have broad utility as a resource that can inform on leukocyte responses to emerging therapies where baseline tissues were not acquired.This article is highlighted in the In This Issue feature, p. 1861.
Collapse
Affiliation(s)
- Shannon M Liudahl
- Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon
| | - Courtney B Betts
- Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon
| | - Shamilene Sivagnanam
- Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.,Computational Biology Program, Oregon Health & Science University, Portland, Oregon
| | | | | | - Chen Yuan
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Samuel Hwang
- Department of Pathology, Oregon Health & Science University, Portland, Oregon
| | - Alison Grossblatt-Wait
- Knight Cancer Institute, Oregon Health & Science University, Portland, OR.,Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, Oregon
| | - Kenna R Leis
- Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon
| | - William Larson
- Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon
| | - Meghan B Lavoie
- Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon
| | - Padraic Robinson
- Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon
| | - Andressa Dias Costa
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Sara A Väyrynen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Thomas E Clancy
- Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
| | - Douglas A Rubinson
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Jason Link
- Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, Oregon.,Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon
| | - Dove Keith
- Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, Oregon
| | - Wesley Horton
- Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.,Computational Biology Program, Oregon Health & Science University, Portland, Oregon
| | - Margaret A Tempero
- Helen Diller Family Comprehensive Cancer Center and Department of Medicine, University of California, San Francisco, California
| | | | - Elizabeth M Jaffee
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland
| | - Brett Sheppard
- Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, Oregon.,Department of Surgery, Oregon Health & Science University, Portland, Oregon
| | - Jeremy Goecks
- Computational Biology Program, Oregon Health & Science University, Portland, Oregon
| | - Rosalie C Sears
- Knight Cancer Institute, Oregon Health & Science University, Portland, OR.,Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, Oregon.,Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon
| | - Byung S Park
- Knight Cancer Institute, Oregon Health & Science University, Portland, OR
| | - Motomi Mori
- Knight Cancer Institute, Oregon Health & Science University, Portland, OR
| | - Jonathan A Nowak
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
| | - Brian M Wolpin
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Lisa M Coussens
- Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon. .,Knight Cancer Institute, Oregon Health & Science University, Portland, OR.,Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, Oregon
| |
Collapse
|
9
|
Bhattacharyya S, Oon C, Kothari A, Horton W, Link J, Sears RC, Sherman MH. Acidic fibroblast growth factor underlies microenvironmental regulation of MYC in pancreatic cancer. J Exp Med 2021; 217:151790. [PMID: 32434218 PMCID: PMC7398167 DOI: 10.1084/jem.20191805] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2019] [Revised: 01/29/2020] [Accepted: 03/02/2020] [Indexed: 12/12/2022] Open
Abstract
Despite a critical role for MYC as an effector of oncogenic RAS, strategies to target MYC activity in RAS-driven cancers are lacking. In genetically engineered mouse models of lung and pancreatic cancer, oncogenic KRAS is insufficient to drive tumorigenesis, while addition of modest MYC overexpression drives robust tumor formation, suggesting that mechanisms beyond the RAS pathway play key roles in MYC regulation and RAS-driven tumorigenesis. Here we show that acidic fibroblast growth factor (FGF1) derived from cancer-associated fibroblasts (CAFs) cooperates with cancer cell–autonomous signals to increase MYC level, promoter occupancy, and activity. FGF1 is necessary and sufficient for paracrine regulation of MYC protein stability, signaling through AKT and GSK-3β to increase MYC half-life. Patient specimens reveal a strong correlation between stromal CAF content and MYC protein level in the neoplastic compartment, and identify CAFs as the specific source of FGF1 in the tumor microenvironment. Together, our findings demonstrate that MYC is coordinately regulated by cell-autonomous and microenvironmental signals, and establish CAF-derived FGF1 as a novel paracrine regulator of oncogenic transcription.
Collapse
Affiliation(s)
- Sohinee Bhattacharyya
- Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR
| | - Chet Oon
- Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR
| | - Aayush Kothari
- Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR
| | - Wesley Horton
- Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR
| | - Jason Link
- Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR
| | - Rosalie C Sears
- Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR
| | - Mara H Sherman
- Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR
| |
Collapse
|
10
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Bagliesi MG, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, Ebisawa K, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Link J, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, de Nolfo GA, Okuno S, Ormes JF, Ospina N, Ozawa S, Pacini L, Palma F, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Sparvoli R, Spillantini P, Stolzi F, Sugita S, Suh JE, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K. Direct Measurement of the Cosmic-Ray Carbon and Oxygen Spectra from 10 GeV/n to 2.2 TeV/n with the Calorimetric Electron Telescope on the International Space Station. Phys Rev Lett 2020; 125:251102. [PMID: 33416351 DOI: 10.1103/physrevlett.125.251102] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/28/2020] [Revised: 09/01/2020] [Accepted: 11/19/2020] [Indexed: 06/12/2023]
Abstract
In this paper, we present the measurement of the energy spectra of carbon and oxygen in cosmic rays based on observations with the Calorimetric Electron Telescope on the International Space Station from October 2015 to October 2019. Analysis, including the detailed assessment of systematic uncertainties, and results are reported. The energy spectra are measured in kinetic energy per nucleon from 10 GeV/n to 2.2 TeV/n with an all-calorimetric instrument with a total thickness corresponding to 1.3 nuclear interaction length. The observed carbon and oxygen fluxes show a spectral index change of ∼0.15 around 200 GeV/n established with a significance >3σ. They have the same energy dependence with a constant C/O flux ratio 0.911±0.006 above 25 GeV/n. The spectral hardening is consistent with that measured by AMS-02, but the absolute normalization of the flux is about 27% lower, though in agreement with observations from previous experiments including the PAMELA spectrometer and the calorimetric balloon-borne experiment CREAM.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - Y Akaike
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M G Bagliesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - E Berti
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - M Bongi
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - N Cannady
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - C Checchia
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Gonzi
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwakecho, Sakyo, Kyoto 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - J Kataoka
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Hakubi Center, Kyoto University, Yoshida Honmachi, Sakyo-ku, Kyoto 606-8501, Japan
- Department of Astronomy, Graduate School of Science, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Kobayashi
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J Link
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology, Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508 Japan
| | - A A Moiseev
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - H M Motz
- Faculty of Science and Engineering, Global Center for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - S Nakahira
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Ave., Denver, Colorado 80208-6900, USA
| | - N Ospina
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - S Ozawa
- Quantum ICT Advanced Development Center, National Institute of Information and Communications Technology, 4-2-1 Nukui-Kitamachi, Koganei, Tokyo 184-8795, Japan
| | - L Pacini
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - F Palma
- INFN Sezione di Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
| | - P Papini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - K Sakai
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - R Sparvoli
- INFN Sezione di Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
- University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
| | - P Spillantini
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - S Sugita
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - J E Suh
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
| | - Y Tsunesada
- Division of Mathematics and Physics, Graduate School of Science, Osaka City University, 3-3-138 Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - E Vannuccini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| |
Collapse
|
11
|
Lu ZC, Haist M, Ivanov D, Jakob C, Jansen D, Schmid M, Kißling PA, Leinitz S, Link J, Mechtcherine V, Neubauer J, Plank J, Schmidt W, Schilde C, Schröfl C, Sowoidnich T, Stephan D. Characterization data of reference cement CEM III/A 42.5N used for priority program DFG SPP 2005 "Opus Fluidum Futurum - Rheology of reactive, multiscale, multiphase construction materials". Data Brief 2020; 30:105524. [PMID: 32322637 PMCID: PMC7168750 DOI: 10.1016/j.dib.2020.105524] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2020] [Revised: 03/24/2020] [Accepted: 03/26/2020] [Indexed: 10/26/2022] Open
Abstract
Two types of cements were selected as the reference cement in the priority program 2005 of the German Research Foundation (DFG SPP 2005). A thorough characterization of CEM I 42.5 R has been made in a recent publication [1]. In this paper, the characterization data of the other reference cement CEM III/A 42.5 N are presented from the aspects of chemical and mineralogical compositions as well as physical and chemical properties. The characterization data of the slag, which is the second main constituent of this specific cement besides the clinker, are presented independently. For all data received, the mean values and the corresponding errors were calculated. The data shall be used for the ongoing research within the priority program. Also, researchers from outside this priority program can benefit from these data if the same materials are used.
Collapse
Affiliation(s)
- Z C Lu
- Department of Civil Engineering, Technische Universität Berlin, 13355 Berlin, Germany
| | - M Haist
- Since 02/2019: Institute of Building Materials, Leibniz Universität Hannover, 30167 Hannover, Germany.,Until 01/2019: Institute of Concrete Structures and Building Materials (IMB), Karlsruhe Institute of Technology, 76131 Karlsruhe, Germany
| | - D Ivanov
- Institute for Particle Technology, Technische Universität Braunschweig, 38106, Braunschweig, Germany
| | - C Jakob
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
| | - D Jansen
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
| | - M Schmid
- Department of Chemistry, Technische Universität München, 85748 Garching, Germany
| | - P A Kißling
- Institute of Physical Chemistry and Electrochemistry, Leibniz Universität Hannover, 30167 Hannover, Germany
| | - S Leinitz
- Bundesanstalt für Materialforschung und - prüfung (BAM), 12205 Berlin, Germany
| | - J Link
- Since 02/2019: Institute of Building Materials, Leibniz Universität Hannover, 30167 Hannover, Germany.,Until 01/2019: Institute of Concrete Structures and Building Materials (IMB), Karlsruhe Institute of Technology, 76131 Karlsruhe, Germany
| | - V Mechtcherine
- Institute of Construction Materials, Technische Universität Dresden, 01159 Dresden, Germany
| | - J Neubauer
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
| | - J Plank
- Department of Chemistry, Technische Universität München, 85748 Garching, Germany
| | - W Schmidt
- Bundesanstalt für Materialforschung und - prüfung (BAM), 12205 Berlin, Germany
| | - C Schilde
- Institute for Particle Technology, Technische Universität Braunschweig, 38106, Braunschweig, Germany
| | - C Schröfl
- Institute of Construction Materials, Technische Universität Dresden, 01159 Dresden, Germany
| | - T Sowoidnich
- F.A. Finger-Insitute for Building Materials, Bauhaus-Universität Weimar, 99421 Weimar, Germany
| | - D Stephan
- Department of Civil Engineering, Technische Universität Berlin, 13355 Berlin, Germany
| |
Collapse
|
12
|
Langer E, Su Y, Joly M, Allen-Petersen B, Farrell A, Worth P, Liefwalker D, Link J, Sheppard B, Sears R. Abstract I16: KRAS and environmental signals regulate MYC to drive lineage plasticity, pancreas cancer progression, and therapeutic resistance. Cancer Res 2019. [DOI: 10.1158/1538-7445.panca19-i16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Cellular plasticity in cancer is emerging as a biomarker of aggressive behavior and an important therapeutic resistance mechanism. The ability of cancer cells to switch lineage and differentiation states provides survival advantages in adverse tumor microenvironments and under therapeutic stress. Pancreatic ductal adenocarcinoma (PDAc) tumors display a dense immunosuppressive microenvironment and a high degree of cellular heterogeneity contributing to poor outcomes. Normally, pancreatic cellular plasticity allows for acinar-to-ductal metaplasia (ADM) in response to inflammation or injury as a reversible process and important mechanism for regeneration of functional tissue. However, mutant KRAS, which is a hallmark of over 90% of PDAc, drives ADM that progresses to ductal precursor lesions (PanINs) and PDAc. We have demonstrated that PDAc can further develop ductal to neuroendocrine lineage plasticity, and that this confers therapeutic resistance and is a biomarker of poor outcomes in patients. This discovery is consistent with other reports in prostate, lung, and breast cancer where neuroendocrine differentiation confers an aggressive, therapeutically resistant state. Mechanistically, we have demonstrated a role for the MYC oncoprotein in PDAc ductal – NE lineage plasticity. MYC is functionally activated by post-translational modifications to a conserved motif, Serine 62-Proline 63, in the MYC N-terminal transactivation domain. In PDAc, KRAS mutations and environmental signaling stimulate MYC Serine 62 phosphorylation and PIN1-mediated Proline 63 isomerization, which promote MYC DNA binding and regulation of pro-oncogenic target genes. We have also observed that cancer-associated fibroblasts (CAFs) can promote PDAc lineage plasticity and that the proline isomerase PIN1 involved in post-translational activation of MYC is also critical for fibroblast activation. Thus, PIN1 has a tumor cell intrinsic and stromal cell function, where loss of PIN1 in pancreatic stellate cells suppresses their activation to CAFs and their support of tumor growth. To understand crosstalk between the tumor microenvironment and cancer cell plasticity, and to develop effective therapeutic strategies that overcome this survival mechanism, we are using 3-D bioprinting to model tumor-stromal interactions and pursuing novel drugs that target post-translational regulation of MYC.
Citation Format: Ellen Langer, Yulong Su, Meghan Joly, Brittany Allen-Petersen, Amy Farrell, Patrick Worth, Dan Liefwalker, Jason Link, Brett Sheppard, Rosalie Sears. KRAS and environmental signals regulate MYC to drive lineage plasticity, pancreas cancer progression, and therapeutic resistance [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Advances in Science and Clinical Care; 2019 Sept 6-9; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2019;79(24 Suppl):Abstract nr I16.
Collapse
Affiliation(s)
- Ellen Langer
- Oregon Health & Science University, Portland, OR
| | - Yulong Su
- Oregon Health & Science University, Portland, OR
| | - Meghan Joly
- Oregon Health & Science University, Portland, OR
| | | | - Amy Farrell
- Oregon Health & Science University, Portland, OR
| | | | | | - Jason Link
- Oregon Health & Science University, Portland, OR
| | | | | |
Collapse
|
13
|
Lu ZC, Haist M, Ivanov D, Jakob C, Jansen D, Leinitz S, Link J, Mechtcherine V, Neubauer J, Plank J, Schmidt W, Schilde C, Schröfl C, Sowoidnich T, Stephan D. Characterization data of reference cement CEM I 42.5 R used for priority program DFG SPP 2005 "Opus Fluidum Futurum - Rheology of reactive, multiscale, multiphase construction materials". Data Brief 2019; 27:104699. [PMID: 31720343 PMCID: PMC6838797 DOI: 10.1016/j.dib.2019.104699] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2019] [Revised: 10/06/2019] [Accepted: 10/15/2019] [Indexed: 11/29/2022] Open
Abstract
A thorough characterization of starting materials is the precondition for further research, especially for cement, which contains various phases and presents quite a complex material for fundamental scientific investigation. In the paper at hand, the characterization data of the reference cement CEM I 42.5 R used within the priority program 2005 of the German Research Foundation (DFG SPP 2005) are presented from the aspects of chemical and mineralogical compositions as well as physical and chemical properties. The data were collected based on tests conducted by nine research groups involved in this cooperative program. For all data received, the mean values and the corresponding errors were calculated. The results shall be used for the ongoing research within the priority program.
Collapse
Affiliation(s)
- Z C Lu
- Department of Civil Engineering, Technische Universität Berlin, 13355, Berlin, Germany
| | - M Haist
- Institute of Building Materials, Leibniz Universität Hannover, 30167, Hannover, Germany.,Institute of Concrete Structures and Building Materials (IMB) and Materials Testing and Research Institute (MPA Karlsruhe), Karlsruher Institue für Technologie, 76131, Karlsruhe, Germany
| | - D Ivanov
- Institute for Particle Technology, Technische Universität Braunschweig, 38106, Braunschweig, Germany
| | - C Jakob
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, 91054, Erlangen, Germany
| | - D Jansen
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, 91054, Erlangen, Germany
| | - S Leinitz
- Bundesanstalt für Materialforschung und - Prüfung (BAM), 12205, Berlin, Germany
| | - J Link
- Institute of Building Materials, Leibniz Universität Hannover, 30167, Hannover, Germany.,Institute of Concrete Structures and Building Materials (IMB) and Materials Testing and Research Institute (MPA Karlsruhe), Karlsruher Institue für Technologie, 76131, Karlsruhe, Germany
| | - V Mechtcherine
- Institute of Construction Materials, Technische Universität Dresden, 01159, Dresden, Germany
| | - J Neubauer
- GeoZentrum Nordbayern, Mineralogy, Friedrich-Alexander Universität Erlangen-Nürnberg, 91054, Erlangen, Germany
| | - J Plank
- Department of Chemistry, Technische Universität München, 85748, Garching, Germany
| | - W Schmidt
- Bundesanstalt für Materialforschung und - Prüfung (BAM), 12205, Berlin, Germany
| | - C Schilde
- Institute for Particle Technology, Technische Universität Braunschweig, 38106, Braunschweig, Germany
| | - C Schröfl
- Institute of Construction Materials, Technische Universität Dresden, 01159, Dresden, Germany
| | - T Sowoidnich
- F.A. Finger-Institute for Building Materials, Bauhaus-Universität Weimar, 99421, Weimar, Germany
| | - D Stephan
- Department of Civil Engineering, Technische Universität Berlin, 13355, Berlin, Germany
| |
Collapse
|
14
|
Hundeyin M, Kurz E, Mishra A, Rossi JAK, Liudahl SM, Leis KR, Mehrotra H, Kim M, Torres LE, Ogunsakin A, Link J, Sears RC, Sivagnanam S, Goecks J, Islam KMS, Dolgalev I, Savadkar S, Wang W, Aykut B, Leinwand J, Diskin B, Adam S, Israr M, Gelas M, Lish J, Chin K, Farooq MS, Wadowski B, Wu J, Shah S, Adeegbe DO, Pushalkar S, Vasudevaraja V, Saxena D, Wong KK, Coussens LM, Miller G. Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming. Cancer Discov 2019; 9:1288-1305. [PMID: 31266770 DOI: 10.1158/2159-8290.cd-19-0161] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2019] [Revised: 05/14/2019] [Accepted: 06/27/2019] [Indexed: 12/16/2022]
Abstract
Unconventional T-lymphocyte populations are emerging as important regulators of tumor immunity. Despite this, the role of TCRαβ+CD4-CD8-NK1.1- innate αβ T cells (iαβT) in pancreatic ductal adenocarcinoma (PDA) has not been explored. We found that iαβTs represent ∼10% of T lymphocytes infiltrating PDA in mice and humans. Intratumoral iαβTs express a distinct T-cell receptor repertoire and profoundly immunogenic phenotype compared with their peripheral counterparts and conventional lymphocytes. iαβTs comprised ∼75% of the total intratumoral IL17+ cells. Moreover, iαβT-cell adoptive transfer is protective in both murine models of PDA and human organotypic systems. We show that iαβT cells induce a CCR5-dependent immunogenic macrophage reprogramming, thereby enabling marked CD4+ and CD8+ T-cell expansion/activation and tumor protection. Collectively, iαβTs govern fundamental intratumoral cross-talk between innate and adaptive immune populations and are attractive therapeutic targets. SIGNIFICANCE: We found that iαβTs are a profoundly activated T-cell subset in PDA that slow tumor growth in murine and human models of disease. iαβTs induce a CCR5-dependent immunogenic tumor-associated macrophage program, T-cell activation and expansion, and should be considered as novel targets for immunotherapy.See related commentary by Banerjee et al., p. 1164.This article is highlighted in the In This Issue feature, p. 1143.
Collapse
Affiliation(s)
- Mautin Hundeyin
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Emma Kurz
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Ankita Mishra
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Juan Andres Kochen Rossi
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Shannon M Liudahl
- Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, Oregon
| | - Kenna R Leis
- Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, Oregon
| | - Harshita Mehrotra
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Mirhee Kim
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Luisana E Torres
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Adesola Ogunsakin
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Jason Link
- Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon.,Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, Portland, Oregon
| | - Rosalie C Sears
- Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon.,Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, Portland, Oregon.,Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon
| | - Shamilene Sivagnanam
- Computational Biology Program, Oregon Health and Science University, Portland, Oregon
| | - Jeremy Goecks
- Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.,Computational Biology Program, Oregon Health and Science University, Portland, Oregon
| | - K M Sadeq Islam
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Igor Dolgalev
- Department of Pathology, New York University School of Medicine, New York, New York
| | - Shivraj Savadkar
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Wei Wang
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Berk Aykut
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Joshua Leinwand
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Brian Diskin
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Salma Adam
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Muhammad Israr
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Maeliss Gelas
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Justin Lish
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Kathryn Chin
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Mohammad Saad Farooq
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Benjamin Wadowski
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Jingjing Wu
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York
| | - Suhagi Shah
- Department of Medicine, New York University School of Medicine, New York, New York
| | - Dennis O Adeegbe
- Department of Medicine, New York University School of Medicine, New York, New York
| | - Smruti Pushalkar
- Department of Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, New York
| | | | - Deepak Saxena
- Department of Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, New York
| | - Kwok-Kin Wong
- Department of Medicine, New York University School of Medicine, New York, New York
| | - Lisa M Coussens
- Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, Oregon.,Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, Portland, Oregon.,Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon
| | - George Miller
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York. .,Department of Cell Biology, New York University School of Medicine, New York, New York
| |
Collapse
|
15
|
Rames MJ, Civitci F, Zheng T, Wagner J, Link J, Nan X. Abstract 799: Aberrant mitochondrial protein involvement through early PDAC initiation and progression using multiplexed DNA-PAINT and correlative histology. Cancer Res 2019. [DOI: 10.1158/1538-7445.am2019-799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Prior to pancreatic ductal adenocarcinoma (PDAC), pancreatic acini cells change their morphology through pancreatic intraepithelial neoplasia (PanIN) stages, becoming increasingly dysplastic as stroma and tissue hypoxia increase. This increasing hypoxia forms a cancer promoting microenvironment, wherein we propose metabolic changes trigger aberrant mitochondrial networks form healthy tissue. We developed tissue superresolution imaging to directly quantify structural mitochondrial response through patient histology, whereby DNA-PAINT can provide super-resolution detail decoupled from photo bleaching to visualize mitochondria through tissue layers. Expanding from preliminary data, target mitochondrial dynamics proteins’ organization will also be correlated to PanIN stages.
Introduction: Early oncogene involvement in PDAC progression links to metabolic and mitochondrial regulatory changes. Typically nutrient deprivation and hypoxia trigger cell death from increased reactive oxygen species production and organelle damage which trigger apoptosis, yet these prolonged effects can be cancer promoting when less severe. Mitochondrial dynamics and proteins related to mitochondrial fission and fusion can reduce apoptotic signaling, enhance aerobic glycolysis, and increase ROS to allow cancer progression.
Materials and Methods: Adapting from previous proof of concept, mitochondria (TOM20) within formalin-fixed paraffin embedded (FFPE) tissue sections were imaged with stochastic optical reconstruction microscopy (STORM). In brief: cadaver healthy pancreas FFPE tissue samples underwent deparafinization, antigen retrieval, indirect immuno-labeling with AlexaFluor647, TIRF illumination with a 60x objective was used for data collection, whereby data processing was conducted using the open-source FIJI and custom MATLAB software.
Results and Discussion: Preliminary data shows proof of principle that both STORM and DNA-PAINT can be correlated to histological staining of human pancreas.
Conclusions: Superresolution imaging reveals ultrastructural details of mitochondria in FFPE patient samples not resolved via conventional fluorescence imaging. Through quantitative feature analysis, we would be able to correlate aberrant mitochondria structure and abundance to PDAC progression.
Acknowledgements: Funding provided by the Cancer Early Detection Advanced Research (CEDAR) Center of OHSU Knight Cancer Institute.
Citation Format: Matthew J. Rames, Fehmi Civitci, Ting Zheng, Josiah Wagner, Jason Link, Xiaolin Nan. Aberrant mitochondrial protein involvement through early PDAC initiation and progression using multiplexed DNA-PAINT and correlative histology [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 799.
Collapse
Affiliation(s)
| | | | - Ting Zheng
- Oregon Health & Science University, Portland, OR
| | | | - Jason Link
- Oregon Health & Science University, Portland, OR
| | - Xiaolin Nan
- Oregon Health & Science University, Portland, OR
| |
Collapse
|
16
|
Skoog B, Link J, Tedeholm H, Longfils M, Nerman O, Fagius J, Andersen O. Short-term prediction of secondary progression in a sliding window: A test of a predicting algorithm in a validation cohort. Mult Scler J Exp Transl Clin 2019; 5:2055217319875466. [PMID: 35145727 PMCID: PMC8822449 DOI: 10.1177/2055217319875466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 08/14/2019] [Accepted: 08/19/2019] [Indexed: 12/03/2022] Open
Abstract
Introduction The Multiple Sclerosis Prediction Score (MSPS, www.msprediction.com) estimates, for any month during the course of relapsing–remitting multiple sclerosis (MS), the individual risk of transition to secondary progression (SP) during the following year. Objective Internal verification of the MSPS algorithm in a derivation cohort, the Gothenburg Incidence Cohort (GIC, n = 144) and external verification in the Uppsala MS cohort (UMS, n = 145). Methods Starting from their second relapse, patients were included and followed for 25 years. A matrix of MSPS values was created. From this matrix, a goodness-of-fit test and suitable diagnostic plots were derived to compare MSPS-calculated and observed outcomes (i.e. transition to SP). Results The median time to SP was slightly longer in the UMS than in the GIC, 15 vs. 11.5 years (p = 0.19). The MSPS was calibrated with multiplicative factors: 0.599 for the UMS and 0.829 for the GIC; the calibrated MSPS provided a good fit between expected and observed outcomes (chi-square p = 0.61 for the UMS), which indicated the model was not rejected. Conclusion The results suggest that the MSPS has clinically relevant generalizability in new cohorts, provided that the MSPS was calibrated to the actual overall SP incidence in the cohort.
Collapse
Affiliation(s)
- B Skoog
- University of Gothenburg, the Sahlgrenska Academy, Institute of Neuroscience and Physiology, Section of Clinical Neuroscience and Rehabilitation, Sweden
| | - J Link
- Department of Clinical Neuroscience, Karolinska Institutet, Sweden
| | - H Tedeholm
- University of Gothenburg, the Sahlgrenska Academy, Institute of Neuroscience and Physiology, Section of Clinical Neuroscience and Rehabilitation, Sweden
| | - M Longfils
- Department of Mathematical Sciences, Chalmers University of Technology, Sweden
| | - O Nerman
- Department of Mathematical Sciences, Chalmers University of Technology, Sweden
| | - J Fagius
- Neurology, Department of Neuroscience, Uppsala University, Sweden
| | - O Andersen
- University of Gothenburg, the Sahlgrenska Academy, Institute of Neuroscience and Physiology, Section of Clinical Neuroscience and Rehabilitation, Sweden
| |
Collapse
|
17
|
Auciello FR, Bulusu V, Oon C, Tait-Mulder J, Berry M, Bhattacharyya S, Tumanov S, Allen-Petersen BL, Link J, Kendsersky ND, Vringer E, Schug M, Novo D, Hwang RF, Evans RM, Nixon C, Dorrell C, Morton JP, Norman JC, Sears RC, Kamphorst JJ, Sherman MH. A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression. Cancer Discov 2019; 9:617-627. [PMID: 30837243 PMCID: PMC6497553 DOI: 10.1158/2159-8290.cd-18-1212] [Citation(s) in RCA: 190] [Impact Index Per Article: 38.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2018] [Revised: 02/03/2019] [Accepted: 02/28/2019] [Indexed: 01/04/2023]
Abstract
Pancreatic ductal adenocarcinoma (PDAC) develops a pronounced stromal response reflecting an aberrant wound-healing process. This stromal reaction features transdifferentiation of tissue-resident pancreatic stellate cells (PSC) into activated cancer-associated fibroblasts, a process induced by PDAC cells but of unclear significance for PDAC progression. Here, we show that PSCs undergo a dramatic lipid metabolic shift during differentiation in the context of pancreatic tumorigenesis, including remodeling of the intracellular lipidome and secretion of abundant lipids in the activated, fibroblastic state. Specifically, stroma-derived lysophosphatidylcholines support PDAC cell synthesis of phosphatidylcholines, key components of cell membranes, and also facilitate production of the potent wound-healing mediator lysophosphatidic acid (LPA) by the extracellular enzyme autotaxin, which is overexpressed in PDAC. The autotaxin-LPA axis promotes PDAC cell proliferation, migration, and AKT activation, and genetic or pharmacologic autotaxin inhibition suppresses PDAC growth in vivo. Our work demonstrates how PDAC cells exploit the local production of wound-healing mediators to stimulate their own growth and migration. SIGNIFICANCE: Our work highlights an unanticipated role for PSCs in producing the oncogenic LPA signaling lipid and demonstrates how PDAC tumor cells co-opt the release of wound-healing mediators by neighboring PSCs to promote their own proliferation and migration.See related commentary by Biffi and Tuveson, p. 578.This article is highlighted in the In This Issue feature, p. 565.
Collapse
Affiliation(s)
- Francesca R Auciello
- Cancer Research UK Beatson Institute, Glasgow, UK
- Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
| | - Vinay Bulusu
- Cancer Research UK Beatson Institute, Glasgow, UK
- Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
| | - Chet Oon
- Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon
| | - Jacqueline Tait-Mulder
- Cancer Research UK Beatson Institute, Glasgow, UK
- Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
| | - Mark Berry
- Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon
| | - Sohinee Bhattacharyya
- Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon
| | - Sergey Tumanov
- Cancer Research UK Beatson Institute, Glasgow, UK
- Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
| | | | - Jason Link
- Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon
| | - Nicholas D Kendsersky
- Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon
| | - Esmee Vringer
- Cancer Research UK Beatson Institute, Glasgow, UK
- Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
| | - Michelle Schug
- Cancer Research UK Beatson Institute, Glasgow, UK
- Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
| | - David Novo
- Cancer Research UK Beatson Institute, Glasgow, UK
| | - Rosa F Hwang
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Ronald M Evans
- The Salk Institute for Biological Studies, Gene Expression Laboratory, Howard Hughes Medical Institute, La Jolla, California
| | - Colin Nixon
- Cancer Research UK Beatson Institute, Glasgow, UK
| | - Craig Dorrell
- Oregon Health & Science University Brenden-Colson Center for Pancreatic Care, Portland, Oregon
| | | | - Jim C Norman
- Cancer Research UK Beatson Institute, Glasgow, UK
| | - Rosalie C Sears
- Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon
| | - Jurre J Kamphorst
- Cancer Research UK Beatson Institute, Glasgow, UK.
- Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
| | - Mara H Sherman
- Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon.
| |
Collapse
|
18
|
Thibault G, Madin O, Azimi V, Meyers C, Johnson B, Link J, Margolin A, Gray JW. Deep learning based Nucleus Classification in pancreas histological images. Annu Int Conf IEEE Eng Med Biol Soc 2018; 2017:672-675. [PMID: 29059962 DOI: 10.1109/embc.2017.8036914] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Tumor specimens contain a variety of healthy cells as well as cancerous cells, and this heterogeneity underlies resistance to various cancer therapies. But this problem has not been thoroughly investigated until recently. Meanwhile, technological breakthroughs in imaging have led to an explosion of molecular and cellular profiling data from large numbers of samples, and modern machine learning approaches including deep learning have been shown to produce encouraging results by finding hidden structures and make accurate predictions. In this paper, we propose a Deep learning based Nucleus Classification (DeepNC) approach using paired histopathology and immunofluorescence images (for label), and demonstrate its classification prediction power. This method can solve current issue on discrepancy between genomic- or transcriptomic-based and pathology-based tumor purity estimates by improving histological evaluation. We also explain challenges in training a deep learning model for huge dataset.
Collapse
|
19
|
Lindenburger K, Link J, Kendsersky N, Cadell M, Agarwal S, Sauer D, Lanciault C, Lopez C, Gilbert E, Sears R, Sheppard B. AB024. S024. Drug responses of patient-derived cell lines in vitro that match drug responses of patient PDAc tumors in situ. ACTA ACUST UNITED AC 2018. [DOI: 10.21037/apc.2018.ab024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
20
|
Link J, Kleist HJ, Henneberg U. A Data Collection Form for Intensive Care Units. Methods Inf Med 2018. [DOI: 10.1055/s-0038-1635391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
The rationale for development of a data collection form for intensive care units is discussed. The form developed in our ICU to facilitate entry of data into video terminals -which document the course of each ICU patient is described. Substantial time saving and reduction in error incidence are obtained, especially so with respect to the coding of diagnoses. The diagnoses and operations are recorded as free text within the constraint of a computer format. For all other data, coding is included as part of the data sheet.
Collapse
|
21
|
Farrell AS, Joly MM, Allen-Petersen BL, Worth PJ, Lanciault C, Sauer D, Link J, Pelz C, Heiser LM, Morton JP, Muthalagu N, Hoffman MT, Manning SL, Pratt ED, Kendsersky ND, Egbukichi N, Amery TS, Thoma MC, Jenny ZP, Rhim AD, Murphy DJ, Sansom OJ, Crawford HC, Sheppard BC, Sears RC. MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance. Nat Commun 2017; 8:1728. [PMID: 29170413 PMCID: PMC5701042 DOI: 10.1038/s41467-017-01967-6] [Citation(s) in RCA: 74] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2017] [Accepted: 10/26/2017] [Indexed: 01/06/2023] Open
Abstract
Intratumoral phenotypic heterogeneity has been described in many tumor types, where it can contribute to drug resistance and disease recurrence. We analyzed ductal and neuroendocrine markers in pancreatic ductal adenocarcinoma, revealing heterogeneous expression of the neuroendocrine marker Synaptophysin within ductal lesions. Higher percentages of Cytokeratin-Synaptophysin dual positive tumor cells correlate with shortened disease-free survival. We observe similar lineage marker heterogeneity in mouse models of pancreatic ductal adenocarcinoma, where lineage tracing indicates that Cytokeratin-Synaptophysin dual positive cells arise from the exocrine compartment. Mechanistically, MYC binding is enriched at neuroendocrine genes in mouse tumor cells and loss of MYC reduces ductal-neuroendocrine lineage heterogeneity, while deregulated MYC expression in KRAS mutant mice increases this phenotype. Neuroendocrine marker expression is associated with chemoresistance and reducing MYC levels decreases gemcitabine-induced neuroendocrine marker expression and increases chemosensitivity. Altogether, we demonstrate that MYC facilitates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma, contributing to poor survival and chemoresistance.
Collapse
MESH Headings
- Animals
- Antineoplastic Agents/therapeutic use
- Carcinoma, Neuroendocrine/drug therapy
- Carcinoma, Neuroendocrine/metabolism
- Carcinoma, Neuroendocrine/pathology
- Carcinoma, Pancreatic Ductal/drug therapy
- Carcinoma, Pancreatic Ductal/metabolism
- Carcinoma, Pancreatic Ductal/pathology
- Cell Differentiation
- Cell Line, Tumor
- Cell Lineage
- Deoxycytidine/analogs & derivatives
- Deoxycytidine/therapeutic use
- Drug Resistance, Neoplasm
- Female
- Heterografts
- Humans
- Keratins/metabolism
- Male
- Mice
- Mice, 129 Strain
- Mice, Inbred C57BL
- Mice, Transgenic
- Neoplasm Transplantation
- Neuroendocrine Cells/metabolism
- Neuroendocrine Cells/pathology
- Pancreatic Neoplasms/drug therapy
- Pancreatic Neoplasms/metabolism
- Pancreatic Neoplasms/pathology
- Prognosis
- Proto-Oncogene Proteins c-myc/metabolism
- Synaptophysin/metabolism
- Gemcitabine
Collapse
Affiliation(s)
- Amy S Farrell
- Department of Molecular and Medical Genetics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Meghan Morrison Joly
- Department of Molecular and Medical Genetics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Brittany L Allen-Petersen
- Department of Molecular and Medical Genetics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Patrick J Worth
- Department of Surgery, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Christian Lanciault
- Department of Pathology, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - David Sauer
- Department of Pathology, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Jason Link
- Department of Molecular and Medical Genetics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
- Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, 3181 S.W Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Carl Pelz
- Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, 3181 S.W Sam Jackson Park Road, Portland, OR, 97239, USA
- Computational Biology, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Laura M Heiser
- Department of Biomedical Engineering and OHSU Center for Spatial Systems Biomedicine, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Jennifer P Morton
- Cancer Research UK, Beatson Institute, Switchback Road, Bearsden, Glasgow, G61 1BD, UK
| | - Nathiya Muthalagu
- Cancer Research UK, Beatson Institute, Switchback Road, Bearsden, Glasgow, G61 1BD, UK
| | - Megan T Hoffman
- Department of Molecular and Integrative Physiology, University of Michigan, 7744 MS II, 1137 E. Catherine St., Ann Arbor, MI, 48109, USA
| | - Sara L Manning
- Department of Gastroenterology, Hepatology and Nutrition and Zayed Center for Pancreatic Cancer Research, University of Texas M.D. Anderson Cancer Center, Unit 1466, 1515 Holcombe Blvd, Houston, TX, 77030, USA
| | - Erica D Pratt
- Department of Gastroenterology, Hepatology and Nutrition and Zayed Center for Pancreatic Cancer Research, University of Texas M.D. Anderson Cancer Center, Unit 1466, 1515 Holcombe Blvd, Houston, TX, 77030, USA
| | - Nicholas D Kendsersky
- Department of Molecular and Medical Genetics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Nkolika Egbukichi
- Department of Molecular and Medical Genetics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Taylor S Amery
- Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, 3181 S.W Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Mary C Thoma
- Department of Molecular and Medical Genetics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Zina P Jenny
- Department of Molecular and Medical Genetics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Andrew D Rhim
- Department of Gastroenterology, Hepatology and Nutrition and Zayed Center for Pancreatic Cancer Research, University of Texas M.D. Anderson Cancer Center, Unit 1466, 1515 Holcombe Blvd, Houston, TX, 77030, USA
| | - Daniel J Murphy
- Cancer Research UK, Beatson Institute, Switchback Road, Bearsden, Glasgow, G61 1BD, UK
- Institute of Cancer Sciences, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK
| | - Owen J Sansom
- Cancer Research UK, Beatson Institute, Switchback Road, Bearsden, Glasgow, G61 1BD, UK
| | - Howard C Crawford
- Department of Molecular and Integrative Physiology, University of Michigan, 7744 MS II, 1137 E. Catherine St., Ann Arbor, MI, 48109, USA
| | - Brett C Sheppard
- Department of Surgery, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
- Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, 3181 S.W Sam Jackson Park Road, Portland, OR, 97239, USA
- Knight Cancer Institute, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA
| | - Rosalie C Sears
- Department of Molecular and Medical Genetics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA.
- Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, 3181 S.W Sam Jackson Park Road, Portland, OR, 97239, USA.
- Knight Cancer Institute, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA.
| |
Collapse
|
22
|
Thibault G, Azimi V, Johnson B, Jorgens D, Link J, Margolin A, Gray JW. Quantitative analysis of histological tissue image based on cytological profiles and spatial statistics. Annu Int Conf IEEE Eng Med Biol Soc 2017; 2016:1175-1178. [PMID: 28324942 DOI: 10.1109/embc.2016.7590914] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The cellular heterogeneity and complex tissue architecture of most tumor samples is a major obstacle in image analysis on standard hematoxylin and eosin-stained (H&E) tissue sections. A mixture of cancer and normal cells complicates the interpretation of their cytological profiles. Furthermore, spatial arrangement and architectural organization of cells are generally not reflected in cellular characteristics analysis. To address these challenges, first we describe an automatic nuclei segmentation of H&E tissue sections. In the task of deconvoluting cellular heterogeneity, we adopt Landmark based Spectral Clustering (LSC) to group individual nuclei in such a way that nuclei in the same group are more similar. We next devise spatial statistics for analyzing spatial arrangement and organization, which are not detectable by individual cellular characteristics. Our quantitative, spatial statistics analysis could benefit H&E section analysis by refining and complementing cellular characteristics analysis.
Collapse
|
23
|
Abstract
Purpose: To evaluate the outcome of our patients with central retinal artery occlusion after local fibrinolysis and to compare these data with results reported in the literature. Material and Methods: Over a period of 7 years, 22 patients (11 male, 11 female, mean age 64.6 ± 12.1 years) were treated with super-selective local fibrinolysis. In 1 case, treatment was carried out via the maxillary-ophthalmic anastomoses due to preexisting occlusion of the ipsilateral internal carotid artery. The latency period from the onset of symptoms to the beginning of therapy was 7.6 ± 1.8 h. Urokinase was used in 7 cases (300,000–1.1 million units) and recombinant tissue plasminogen activator (20–40 mg) was applied in 15 patients. Visual acuity and fundus were examined before and after treatment. Results: One patient (1/22 = 4.6%) recovered completely and regained a visual acuity of 20/20. Six patients (6/22 = 27.3%) showed a marked improvement with a range of visual outcome from 20/800 to 20/320. In 2 cases (2/22 = 9.1%) only a slight improvement was observed, with a visual outcome allowing detection of hand movements. In 13 cases (13/22 = 59.1%) no change in visual acuity as a result of treatment was observed. In 2/22 cases (9.2%) reversible neurological side-effects occurred, in 1 case suffered a stroke, and in another case intracerebral bleeding was observed. Conclusion: In our study, the recovery of visual acuity and the complication rate were not as positive as reported in the literature.
Collapse
Affiliation(s)
- B Butz
- Department of Radiology, University of Regensburg Hospital, Regensburg, Germany.
| | | | | | | | | | | |
Collapse
|
24
|
Xiu J, Obeid E, Gatalica Z, Reddy S, Goldstein LJ, Link J, Waisman J. Abstract P3-07-26: Biomarker comparison between androgen receptor – Positive-triple-negative breast cancer (AR+ TNBC) and quadruple-negative breast cancer (QNBC). Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p3-07-26] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Quadruple-negative breast cancer (QNBC) is a subgroup of triple-negative breast cancer (TNBC) that lacks androgen receptor (AR) expression. While TNBC patients with AR expression have shown a promising response to AR-targeted therapies, QNBC patients' treatment options remain limited, with no targeted therapy We investigated the biomarker profiles of large cohorts of AR+TNBC and QNBC to identify their molecular differences.
Method: TNBC tumors (defined as negative by IHC for ER, PR, Her2 and ISH for Her2) referred to Caris Life Sciences (Phoenix, AZ) between 2009 and 2015 were evaluated by board-certified pathologists with a combination of immunohistochemistry (AR, cKIT, cMET, EGFR, ER, ERCC1, Her2, MGMT, PD-1, PD-L1, PGP, PR, PTEN, RRM1, SPARC, TLE3, TOPO2A, TOPO1, TS and TUBB3), fluorescent/chromogenic in-situ hybridization (cMET, EGFR, Her2, TOP2A), and sequencing (Next-generation and Sanger). Tumors evaluated included a mix of primary tumors and metastases. QNBC tumors were defined as TNBC tumors that showed negative AR expression (<10% of cells staining).
Results: Among 2,071 TNBC tumors identified, 1,952 tumors had AR IHC performed, out of which 1,612 (83%) were QNBC and 340 (17%) were AR+ TNBC tumors. Tumor expression of PD-L1 (Ab: SP142, Spring Bioscience/130021, R&D Systems, cutoff used: 2+, 5%) was significantly higher in QNBC compared to AR+TNBC tumors (18% vs. 8%, p=0.01), while PD-1 (Ab: NAT105, Ventana) expression on tumor-infiltrating lymphocytes was comparable between the two cohorts (60% vs. 62%). QNBC tumors were significantly more likely to express proteins of cKIT (26% vs. 15%, p=0.01), EGFR (69% vs. 56%, p=0.03), TS (49% vs. 33%, p<0.0001) and TOPO2A (85% vs. 65%, p<0.0001) compared to AR+TNBC. TLE3 expression was significantly higher in AR+TNBC cohorts (48% vs. 32%, p<0.0001). Sequencing reveals that QNBC tumors carried significantly higher mutation rate of TP53 (71% vs. 55%, p<0.0001) while AR+TNBC tumors showed significantly higher mutation rates of PIK3CA (42% vs. 12%, p<0.0001), AKT1 (13% vs. 1%, p<0.0001) as well as ERBB2 (5% vs. 1%, p=0.0003).
Conclusion:
Biomarker comparisons between two molecular subgroups of the TNBC tumors confirm the molecular heterogeneity of this aggressive type of breast cancer. Our biomarker results suggests that for AR+TNBC tumors, future clinical trial design can consider fluoropyrimidines, taxanes, and agents targeting PI3K/AKT/mTOR pathway as well as pan-HER inhibitors, and those agents may be combined with anti-androgen therapies. On the other hand, clinical trials for immune checkpoint inhibitors, TOP2A inhibitors, as well as agents that target cKIT and EGFR should be considered for QNBC tumors. Our findings highlight the molecular differences that should be considered in the design of future clinical trial strategies, warranting further investigation for improving targeted therapy and outcomes in TNBC.
Citation Format: Xiu J, Obeid E, Gatalica Z, Reddy S, Goldstein LJ, Link J, Waisman J. Biomarker comparison between androgen receptor – Positive-triple-negative breast cancer (AR+ TNBC) and quadruple-negative breast cancer (QNBC). [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P3-07-26.
Collapse
Affiliation(s)
- J Xiu
- Caris Life Sciences, Phoenix, AZ; Breastlink Medical Group, Orange, CA; City of Hope Medical Onclogy, Duarte, CA; Fox Chase Cancer Center, Philadelphia, PA
| | - E Obeid
- Caris Life Sciences, Phoenix, AZ; Breastlink Medical Group, Orange, CA; City of Hope Medical Onclogy, Duarte, CA; Fox Chase Cancer Center, Philadelphia, PA
| | - Z Gatalica
- Caris Life Sciences, Phoenix, AZ; Breastlink Medical Group, Orange, CA; City of Hope Medical Onclogy, Duarte, CA; Fox Chase Cancer Center, Philadelphia, PA
| | - S Reddy
- Caris Life Sciences, Phoenix, AZ; Breastlink Medical Group, Orange, CA; City of Hope Medical Onclogy, Duarte, CA; Fox Chase Cancer Center, Philadelphia, PA
| | - LJ Goldstein
- Caris Life Sciences, Phoenix, AZ; Breastlink Medical Group, Orange, CA; City of Hope Medical Onclogy, Duarte, CA; Fox Chase Cancer Center, Philadelphia, PA
| | - J Link
- Caris Life Sciences, Phoenix, AZ; Breastlink Medical Group, Orange, CA; City of Hope Medical Onclogy, Duarte, CA; Fox Chase Cancer Center, Philadelphia, PA
| | - J Waisman
- Caris Life Sciences, Phoenix, AZ; Breastlink Medical Group, Orange, CA; City of Hope Medical Onclogy, Duarte, CA; Fox Chase Cancer Center, Philadelphia, PA
| |
Collapse
|
25
|
Xiu J, Gatalica Z, Reddy S, Waisman J, Link J. Abstract P3-07-27: Distinct biomarker features in triple-negative breast cancer metastases to the brain, liver and bone. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p3-07-27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Triple-negative breast cancer (TNBC) is characterized by its aggressive nature and accounts for a disproportionate number of metastatic disease cases and breast cancer-related deaths. Despite recent improvements, TNBC patients who develop metastatic diseases have limited treatment options. We investigated biomarkers from brain, liver and bone metastases collected from TNBC patients to identify therapeutic options and to examine molecular differences between the metastatic sites.
Method: Triple-negative breast cancer tumors referred to Caris Life Sciences (Phoenix, AZ) between 2009 and 2015 were tested with a combination of immunohistochemistry, fluorescent/chromogenic in-situ hybridization and sequencing (Next-generation and Sanger).
Result: 1570 TNBC tumors were analyzed, including 1297 tumors taken from breast, 54 from brain, 172 from liver and 47 from bone. Select biomarker frequencies of protein overexpression (IHC), gene amplification (ISH) and mutations (SEQ) are summarized in Table 1. Brain metastases showed the highest protein expression of TOPO2A and PDL1; liver metastases showed the highest expression of AR and SPARC, as well as the highest mutation rate of PIK3CA. Bone metastases showed the lowest expression of TS, RRM1 and ERCC1. BRCA1 and BRCA2 mutation rates ranged from 0-11% in various specimen sites.
Table 1Biomarker and MethodBreast Metastases (%)Brain Metastases (%)Liver Metastases (%)Bone Metastases (%)p value[pound]TOP2A IHC76100[sect]7339<0.0001PDL1 IHC1540[sect]8170.03AR IHC151036[sect]260.0005SPARC IHC173040[sect]150.0027PIK3CA SEQ165.329[sect]250.036TS IHC[dagger]49542415[sect]<0.0001RRM1 IHC[dagger]39433216[sect]0.006ERCC1 IHC[dagger]35554816[sect]0.002BRCA1 SEQ708n/ansBRCA2 SEQ11114n/ans[sect]:the group with the highest frequency of actionable results; [pound]:p values are calculated from comparing the group with the highest frequency with the lowest frequency using two tailed Fisher-Exact test, further detailed statistical analysis will be presented;[dagger]:low levels predict response to associated drugs; Ns: non-significant, i.e., p >0.05; n/a: data not available due to low N
Conclusion: Distinct biomarker features identified in different metastatic sites in TNBC present the rationale to investigate differential treatment strategies. Based on biomarker results, etoposide, immune-modulatory agents may seem promising for brain metastases; anti-androgen therapies and nab-paclitaxel may be promising in treating liver metastases; while fluoropyrimidines, gemcitabine and platinum may be considered for TNBC patients with bone metastases.
Citation Format: Xiu J, Gatalica Z, Reddy S, Waisman J, Link J. Distinct biomarker features in triple-negative breast cancer metastases to the brain, liver and bone. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P3-07-27.
Collapse
Affiliation(s)
- J Xiu
- Caris Life Sciences, Phoenix, AZ; City of Hope Medical Oncology, Duarte, CA; Breastlink Medical Group, Orange, CA
| | - Z Gatalica
- Caris Life Sciences, Phoenix, AZ; City of Hope Medical Oncology, Duarte, CA; Breastlink Medical Group, Orange, CA
| | - S Reddy
- Caris Life Sciences, Phoenix, AZ; City of Hope Medical Oncology, Duarte, CA; Breastlink Medical Group, Orange, CA
| | - J Waisman
- Caris Life Sciences, Phoenix, AZ; City of Hope Medical Oncology, Duarte, CA; Breastlink Medical Group, Orange, CA
| | - J Link
- Caris Life Sciences, Phoenix, AZ; City of Hope Medical Oncology, Duarte, CA; Breastlink Medical Group, Orange, CA
| |
Collapse
|
26
|
Mural Z, Kolnes M, Afshari H, Kollo L, Link J, Veinthal R. Fabrication and microstructural analysis of didymium–iron–boron magnet alloys with cerium additions. Proc Estonian Acad Sci 2016. [DOI: 10.3176/proc.2016.2.02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
27
|
Caminata A, Agostini M, Altenmüller K, Appel S, Bellini G, Benziger J, Berton N, Bick D, Bonfini G, Bravo D, Caccianiga B, Calaprice F, Cavalcante P, Chepurnov A, Cribier M, D'Angelo D, Davini S, Derbin A, Noto LD, Durero M, Empl A, Etenko A, Farinon S, Fischer V, Fomenko K, Franco D, Gabriele F, Gaffiot J, Galbiati C, Ghiano C, Giammarchi M, Göger-Neff M, Goretti A, Gromov M, Hagner C, Houdy T, Hungerford E, Ianni A, Ianni A, Jonquères N, Kaiser M, Kobychev V, Korablev D, Korga G, Kryn D, Lachenmaier T, Lasserre T, Laubenstein M, Lehnert B, Link J, Litvinovich E, Lombardi F, Lombardi P, Ludhova L, Lukyanchenko G, Machulin I, Maneschg W, Marcocci S, Maricic J, Mention G, Meroni E, Meyer M, Miramonti L, Misiaszek M, Montuschi M, Muratova V, Musenich R, Neumair B, Oberauer L, Obolensky M, Ortica F, Pallavicini M, Papp L, Perasso L, Pocar A, Ranucci G, Razeto A, Re A, Romani A, Rossi N, Schönert S, Scola L, Simgen H, Skorokhvatov M, Smirnov O, Sotnikov A, Sukhotin S, Suvorov Y, Tartaglia R, Testera G, Veyssière C, Vivier M, Vogelaar R, Feilitzsch FV, Wang H, Winter J, Wojcik M, Wurm M, Zaimidoroga O, Zavatarelli S, Zuber K, Zuzel G. Short distance neutrino oscillations with Borexino. EPJ Web of Conferences 2016. [DOI: 10.1051/epjconf/201612101002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
28
|
Lawitz E, Freilich B, Link J, German P, Mo H, Han L, Brainard DM, McNally J, Marbury T, Rodriguez-Torres M. A phase 1, randomized, dose-ranging study of GS-5816, a once-daily NS5A inhibitor, in patients with genotype 1-4 hepatitis C virus. J Viral Hepat 2015; 22:1011-9. [PMID: 26183611 DOI: 10.1111/jvh.12435] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2015] [Accepted: 05/28/2015] [Indexed: 12/13/2022]
Abstract
GS-5816 is an inhibitor of the hepatitis C virus (HCV) NS5A protein that has demonstrated pan-genotypic activity and a high barrier to resistance in HCV replicon assays. The aim of this study was to evaluate the safety, antiviral activity and pharmacokinetics of once-daily doses of GS-5816 in patients with genotype 1-4 HCV infection. Patients with genotype 1-4 HCV infection were randomized to 3 days of GS-5816 at doses ranging from 5 to 150 mg or placebo. Adverse events were recorded, and plasma samples obtained for analysis of pharmacokinetics, HCV RNA and NS5A sequencing studies. GS-5816 5-150 mg for 3 days was well tolerated and resulted in rapid declines in HCV RNA that were sustained over the dosing period. In patients treated with the 150 mg dose of GS-5816, the mean maximal HCV RNA declines were 4.0, 4.0, 4.4, 3.3 and 3.5 log10 IU/mL in patients with genotype 1a, 1b, 2, 3 and 4 HCV infection, respectively. Pretreatment NS5A resistance-associated polymorphisms were detected in 31% (22/70) of patients. Genotype 1 and 3 HCV-infected patients without pretreatment NS5A resistance-associated polymorphisms had greater declines in HCV RNA than patients with resistance-associated polymorphisms. Plasma pharmacokinetics were supportive of once-daily dosing. GS-5816 demonstrated pangenotypic antiviral activity in patients with genotype 1-4 HCV infection. It will be further evaluated in combination with other pangenotypic direct-acting antivirals to achieve the goal of developing a well-tolerated, highly effective treatment for all HCV genotypes.
Collapse
Affiliation(s)
- E Lawitz
- Texas Liver Institute, University of Texas Health Sciences Center, San Antonio, TX, USA
| | - B Freilich
- Kansas City Gastroenterology and Hepatology, Kansas City, MO, USA
| | - J Link
- Gilead Sciences, Inc., Foster City, CA, USA
| | - P German
- Gilead Sciences, Inc., Foster City, CA, USA
| | - H Mo
- Gilead Sciences, Inc., Foster City, CA, USA
| | - L Han
- Gilead Sciences, Inc., Foster City, CA, USA
| | | | - J McNally
- Gilead Sciences, Inc., Foster City, CA, USA
| | - T Marbury
- Orlando Clinical Research Center, Orlando, FL, USA
| | | |
Collapse
|
29
|
Tirado C, Link J, Golden C, Amen D, Willeumier K, Taylor D. C-22SPECT Differences in the Factor of Disorganization/Impulsivity at Baseline and. Arch Clin Neuropsychol 2015. [DOI: 10.1093/arclin/acv047.224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
30
|
Link J, Messerly J, Driskell L, Pinjala M, Golden C. NEUROPSYCHOLOGICAL DOMAINS: MEMORY AND AMNESIAC-40Simple Mediating Effects of Stroop Color Word Trial on the Association between Processing Speed and Immediate Memory. Arch Clin Neuropsychol 2015. [DOI: 10.1093/arclin/acv047.242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
31
|
Pinjala M, Link J, Golden C. NEUROPSYCHOLOGICAL DOMAINS: ATTENTIONC-15Performance Decline on Digit Span Subtests as a Predictor of Task Vigilance. Arch Clin Neuropsychol 2015. [DOI: 10.1093/arclin/acv047.217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
32
|
Messerly J, Link J, Golden C. AGING AND DEMENTIA: OTHERB-15A Comparison of the Relationship between Trails B Variables to Driving Errors in an Older and Younger Adult Population. Arch Clin Neuropsychol 2015. [DOI: 10.1093/arclin/acv047.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
33
|
Driskell L, Pinjala M, Link J, Golden C. NEUROPSYCHOLOGICAL DOMAINS: LANGUAGE AND APHASIAB-88The Relationship between Educational Level and the Boston Naming Test in Alzheimer's Patients. Arch Clin Neuropsychol 2015. [DOI: 10.1093/arclin/acv047.183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
34
|
Keith DA, Rodríguez JP, Brooks TM, Burgman MA, Barrow EG, Bland L, Comer PJ, Franklin J, Link J, McCarthy MA, Miller RM, Murray NJ, Nel J, Nicholson E, Oliveira-Miranda MA, Regan TJ, Rodríguez-Clark KM, Rouget M, Spalding MD. The IUCN Red List of Ecosystems: Motivations, Challenges, and Applications. Conserv Lett 2015. [DOI: 10.1111/conl.12167] [Citation(s) in RCA: 109] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Affiliation(s)
- David A. Keith
- Centre for Ecosystem Science; University of New South Wales; Sydney New South Wales Australia
- New South Wales Office of Environment and Heritage; Hurstville New South Wales Australia
- Long Term Ecological Research Network, Terrestrial Ecosystem Research Network; Australian National University; Canberra Australian Capital Territory Australia
- IUCN Commission on Ecosystem Management; Gland Switzerland
- IUCN Species Survival Commission; Gland Switzerland
| | - Jon Paul Rodríguez
- IUCN Commission on Ecosystem Management; Gland Switzerland
- IUCN Species Survival Commission; Gland Switzerland
- Centro de Ecología; Instituto Venezolano de Investigaciones Científicas; Caracas Venezuela
- Provita; Caracas Venezuela
| | | | - Mark A. Burgman
- Centre of Excellence for Biosecurity Risk Analysis, School of Botany; The University of Melbourne; Victoria Australia
| | | | - Lucie Bland
- ARC Centre of Excellence for Environmental Decisions, School of Botany; The University of Melbourne; Victoria Australia
| | | | - Janet Franklin
- School of Geographical Sciences & Urban Planning; Arizona State University; Tempe Arizona USA
| | - Jason Link
- NOAA Fisheries; Woods Hole; Massachusetts USA
| | - Michael A. McCarthy
- ARC Centre of Excellence for Environmental Decisions, School of Botany; The University of Melbourne; Victoria Australia
| | - Rebecca M. Miller
- IUCN Global Ecosystem Management Programme; Cambridge United Kingdom
| | - Nicholas J. Murray
- Centre for Ecosystem Science; University of New South Wales; Sydney New South Wales Australia
| | - Jeanne Nel
- Biodiversity & Ecosystem Services; Natural Resources & the Environment, CSIR; South Africa
| | - Emily Nicholson
- ARC Centre of Excellence for Environmental Decisions, School of Botany; The University of Melbourne; Victoria Australia
- School of Life and Environmental Sciences; Deakin University; Burwood Victoria Australia
- Centre for Integrative Ecology, School of Life and Environmental Sciences; Deakin University; Burwood Victoria 3125 Australia
| | | | - Tracey J. Regan
- ARC Centre of Excellence for Environmental Decisions, School of Botany; The University of Melbourne; Victoria Australia
- Arthur Rylah Institute for Environmental Research, Department of Environment; Land, Water and Planning; Heidelberg Victoria Australia
| | - Kathryn M. Rodríguez-Clark
- Long Term Ecological Research Network, Terrestrial Ecosystem Research Network; Australian National University; Canberra Australian Capital Territory Australia
| | - Mathieu Rouget
- Land Use Planning and Management, School of Agricultural, Earth and Environmental Sciences; University of KwaZulu; Natal South Africa
| | - Mark D. Spalding
- The Nature Conservancy and Conservation Science Group, Department of Zoology; University of Cambridge; Cambridge England
| |
Collapse
|
35
|
Link J, Messerly J, Spearman C, Driskell L, Coad S, Amen D, Willeumier K, Taylor D, Golden C. C-09 * SPECT Differences between Those with Higher and Lower Levels of Aggression: An Exploratory Analysis. Arch Clin Neuropsychol 2014. [DOI: 10.1093/arclin/acu038.190] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
36
|
Driskell L, Link J, Amen D, Willeumier K, Taylor D, Golden C. C-16 * A SPECT Exploratory Analysis of Differentiating Mania Symptomology Severity. Arch Clin Neuropsychol 2014. [DOI: 10.1093/arclin/acu038.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
37
|
Messerly J, Link J, Coad S, Hayhurst H, Golden C. B-80 * The Relationship between WAIS-IV Perceptual Reasoning and Processing Speed Indices to Driving Tickets/Violations. Arch Clin Neuropsychol 2014. [DOI: 10.1093/arclin/acu038.168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
38
|
Messerly J, Link J, Hayhurst H, Roberts C, Amen D, Willeumier K, Taylor D, Golden C. C-19 * A Preliminary Investigation of SPECT Differences between Individuals with Varying Levels of Anxiety. Arch Clin Neuropsychol 2014. [DOI: 10.1093/arclin/acu038.200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
39
|
Parke E, Hart J, Baldock D, Barchard K, Etcoff L, Allen D, Stolberg P, Nardi N, Cohen J, Jones W, Loe S, Etcoff L, Delgaty L, Tan A, Bunner M, Delgaty L, Tan A, Bunner M, Tan A, Delgaty L, Bunner M, Tan A, Delgaty L, Bunner M, Goodman G, Kim W, Nolty A, Marion S, Davis A, Finch W, Piehl J, Moss L, Nogin R, Dean R, Davis J, Lindstrom W, Poon M, Fonseca F, Bure-Reyes A, Stewart J, Golden C, Fonseca F, Bure-Reyes A, Stewart J, Golden C, Fields K, Hill B, Corley E, Russ K, Boettcher A, Musso M, Rohling M, Rowden A, Downing K, Benners M, Miller D, Maricle D, Dugbartey T, Anum A, Anderson J, Daniel M, Hoskins L, Gillis K, Khen S, Carter K, Ayers C, Neeland I, Cullum M, Weiner M, Rossetti H, Buddin W, Mahal S, Schroeder R, Baade L, Macaluso M, Phelps K, Evans C, Clark J, Vickery C, Chow J, Stokic D, Phelps K, Evans C, Watson S, Odom R, Clark J, Clark J, Odom R, Evans C, Vickery C, Thompson J, Noggle C, Kane C, Kecala N, Lane E, Raymond M, Woods S, Iudicello J, Dawson M, Ghias A, Choe M, Yudovin S, McArthur D, Asarnow R, Giza C, Babikian T, Tun S, O'Neil M, Ensley M, Storzbach D, Ellis R, O'Neil M, Carlson K, Storzbach D, Brenner L, Freeman M, Quinones A, Motu'apuaka M, Ensley M, Kansagara D, Brickell T, Grant I, Lange R, Kennedy J, Ivins B, Marshall K, Prokhorenko O, French L, Brickell T, Lange R, Bhagwat A, French L, Weber E, Nemeth D, Songy C, Gremillion A, Lange R, Brubacher J, Shewchuk J, Heran M, Jarrett M, Rauscher A, Iverson G, Woods S, Ukueberuwa D, Medaglia J, Hillary F, Meyer J, Vargas G, Rabinowitz A, Barwick F, Arnett P, Levan A, Gale S, Atkinson J, Boettcher A, Hill B, Rohling M, Stolberg P, Hart J, Allen D, Mayfield J, Ellis M, Marion SD, Houshyarnejad A, Grant I, Akarakian R, Kernan C, Babikian T, Asarnow R, Bens M, Fisher M, Garrett C, Vinogradov S, Walker K, Torstrick A, Uderman J, Wellington R, Zhao L, Fromm N, Dahdah M, Salisbury D, Monden K, Lande E, Wanlass R, Fong G, Smith K, Miele A, Novakovic-Agopian T, Chen A, Rome S, Rossi A, Abrams G, Murphy M, Binder D, Muir J, Carlin G, Loya F, Rabinovitz B, Bruhns M, Adler M, Schleicher-Dilks S, Messerly J, Babika C, Ukpabi C, Golden C, Schleicher-Dilks S, Coad S, Messerly J, Schaffer S, Babika C, Golden C, Cowad S, Paisley S, Fontanetta R, Messerly J, Golden C, Holder C, Kloezeman K, Henry B, Burns W, Patt V, Minassian A, Perry W, Cooper L, Allen D, Vogel S, Woolery H, Ciobanu C, Simone A, Bedard A, Olivier T, O'Neill S, Rajendran K, Halperin J, Rudd-Barnard A, Steenari M, Murry J, Le M, Becker T, Mucci G, Zupanc M, Shapiro E, Santos O, Cadavid N, Giese E, Londono N, Osmon D, Zamzow J, Culnan E, D'Argenio D, Mosti C, Spiers M, Schleicher-Dilks S, Kloss J, Curiel A, Miller K, Olmstead R, Gottuso A, Saucier C, Miller J, Dye R, Small G, Kent A, Andrews P, Puente N, Terry D, Faraco C, Brown C, Patel A, Siegel J, Miller L, Lee B, Joan M, Thaler N, Fontanetta R, Carla F, Allen D, Nguyen T, Glass L, Coles C, Julie K, May P, Sowell E, Jones K, Riley E, Demsky Y, Mattson S, Allart A, Freer B, Tiersky L, Sunderaraman P, Sylvester P, Ang J, Schultheis M, Newton S, Holland A, Burns K, Bunting J, Taylor J, Muetze H, Coe M, Harrison D, Putnam M, Tiersky L, Freer B, Holland A, Newton S, Sakamoto M, Bunting J, Taylor J, Coe M, Harrison D, Musso M, Hill B, Barker A, Pella R, Gouvier W, Davis J, Woods S, Wall J, Etherton J, Brand T, Hummer B, O'Shea C, Segovia J, Thomlinson S, Schulze E, Roskos P, Gfeller J, Loftis J, Fogel T, Barrera K, Sherzai A, Chappell A, Harrison A, Armstrong I, Flaro L, Pedersen H, Shultz LS, Roper B, Huckans M, Basso M, Silk-Eglit G, Stenclik J, Miele A, Lynch J, McCaffrey R, Silk-Eglit G, Stenclik J, Miele A, Lynch J, Musso M, McCaffrey R, Martin P, VonDran E, Baade L, Heinrichs R, Schroeder R, Hunter B, Calloway J, Rolin S, Akeson S, Westervelt H, Mohammed S, An K, Jeffay E, Zakzanis K, Lynch A, Drasnin D, Ikanga J, Graham O, Reid M, Cooper D, Long J, Lange R, Kennedy J, Hopewell C, Lukaszewska B, Pachalska M, Bidzan M, Lipowska M, McCutcheon L, Kaup A, Park J, Morgan E, Kenton J, Norman M, Martin P, Netson K, Woods S, Smith M, Paulsen J, Hahn-Ketter A, Paxton J, Fink J, Kelley K, Lee R, Pliskin N, Segala L, Vasilev G, Bozgunov K, Naslednikova R, Raynov I, Gonzalez R, Vassileva J, Bonilla X, Fedio A, Johnson K, Sexton J, Blackstone K, Weber E, Moore D, Grant I, Woods S, Pimental P, Welch M, Ring M, Stranks E, Crowe S, Jaehnert S, Ellis C, Prince C, Wheaton V, Schwartz D, Loftis J, Fuller B, Hoffman W, Huckans M, Turecka S, McKeever J, Morse C, Schultheis M, Dinishak D, Dasher N, Vik P, Hachey D, Bowman B, Van Ness E, Williams C, Zamzow J, Sunderaraman P, Kloss J, Spiers M, Swirsky-Sacchetti T, Alhassoon O, Taylor M, Sorg S, Schweinsburg B, Stricker N, Kimmel C, Grant I, Alhassoon O, Taylor M, Sorg S, Schweinsburg B, Stephan R, Stricker N, Grant I, Hertza J, Tyson K, Northington S, Loughan A, Perna R, Davis A, Collier M, Schroeder R, Buddin W, Schroeder R, Moore C, Andrew W, Ghelani A, Kim J, Curri M, Patel S, Denney D, Taylor S, Huberman S, Greenberg B, Lacritz L, Brown D, Hughes S, Greenberg B, Lacritz L, Vargas V, Upshaw N, Whigham K, Peery S, Casto B, Barker L, Otero T, La D, Nunan-Saah J, Phoong M, Gill S, Melville T, Harley A, Gomez R, Adler M, Tsou J, Schleicher-Dilks S, Golden C, Tsou J, Schleicher-Dilks S, Adler M, Golden C, Cowad S, Link J, Barker T, Gulliver K, Golden C, Young K, Moses J, Lum J, Vik P, Legarreta M, Van Ness E, Williams C, Dasher N, Williams C, Vik P, Dasher N, Van Ness E, Bowman B, Nakhutina L, Margolis S, Baek R, Gonzalez J, Hill F, England H, Horne-Moyer L, Stringer A, DeFilippis N, Lyon A, Giovannetti T, Fanning M, Heverly-Fitt S, Stambrook E, Price C, Selnes O, Floyd T, Vogt E, Thiruselvam I, Quasney E, Hoelzle J, Grant N, Moses J, Matevosyan A, Delano-Wood L, Alhassoon O, Hanson K, Lanni E, Luc N, Kim R, Schiehser D, Benners M, Downing K, Rowden A, Miller D, Maricle D, Kaminetskaya M, Moses J, Tai C, Kaminetskaya M, Melville T, Poole J, Scott R, Hays F, Walsh B, Mihailescu C, Douangratdy M, Scott B, Draffkorn C, Andrews P, Schmitt A, Waksmunski C, Brady K, Andrews A, Golden C, Olivier T, Espinoza K, Sterk V, Spengler K, Golden C, Olivier T, Spengler K, Sterk V, Espinoza K, Golden C, Gross J, DeFilippis N, Neiman-Kimel J, Romers C, Isaacs C, Soper H, Sordahl J, Tai C, Moses J, D'Orio V, Glukhovsky L, Beier M, Shuman M, Spat J, Foley F, Guatney L, Bott N, Moses J, Miranda C, Renteria MA, Rosario A, Sheynin J, Fuentes A, Byrd D, Mindt MR, Batchelor E, Meyers J, Patt V, Thomas M, Minassian A, Geyer M, Brown G, Perry W, Smith C, Kiefel J, Rooney A, Gouaux B, Ellis R, Grant I, Moore D, Graefe A, Wyman-Chick K, Daniel M, Beene K, Jaehnert S, Choi A, Moses J, Iudicello J, Henry B, Minassian A, Perry W, Marquine M, Morgan E, Letendre S, Ellis R, Woods S, Grant I, Heaton R, Constantine K, Fine J, Palewjala M, Macher R, Guatney L, Earleywine M, Draffkorn C, Scott B, Andrews P, Schmitt A, Dudley M, Silk-Eglit G, Stenclik J, Miele A, Lynch J, McCaffrey R, Scharaga E, Gomes W, McGinley J, Miles-Mason E, Colvin M, Carrion L, Romers C, Soper H, Zec R, Kohlrus S, Fritz S, Robbs R, Ala T, Zec R, Fritz S, Kohlrus S, Robbs R, Ala T, Edwards M, Hall J, O'Bryant S, Miller J, Dye R, Miller K, Baerresen K, Small G, Moskowitz J, Puente A, Ahmed F, Faraco C, Brown C, Evans S, Chu K, Miller L, Young-Bernier M, Tanguay A, Tremblay F, Davidson P, Duda B, Puente A, Terry D, Kent A, Patel A, Miller L, Junod A, Marion SD, Harrington M, Fonteh A, Gurnani A, John S, Gavett B, Diaz-Santos M, Mauro S, Beaute J, Cronin-Golomb A, Fazeli P, Gouaux B, Rosario D, Heaton R, Moore D, Puente A, Lindbergh C, Chu K, Evans S, Terry D, Duda B, Mackillop J, Miller S, Greco S, Klimik L, Cohen J, Robbins J, Lashley L, Schleicher-Dilks S, Golden C, Kunkes I, Culotta V, Kunkes I, Griffits K, Loughan A, Perna R, Hertza J, Cohen M, Northington S, Tyson K, Musielak K, Fine J, Kaczorowski J, Doty N, Braaten E, Shah S, Nemanim N, Singer E, Hinkin C, Levine A, Gold A, Evankovich K, Lotze T, Yoshida H, O'Bryan S, Roberg B, Glusman M, Ness A, Thelen J, Wilson L, Feaster T, Bruce J, Lobue C, Brown D, Hughes S, Greenberg B, Lacritz L, Bristow-Murray B, Andrews A, Bermudez C, Golden C, Moore R, Pulver A, Patterson T, Bowie C, Harvey P, Jeste D, Mausbach B, Wingo J, Fink J, Lee R, Pliskin N, Legenkaya A, Henry B, Minassian A, Perry W, McKeever J, Morse C, Thomas F, Schultheis M, Ruocco A, Daros A, Gill S, Grimm D, Saini G, Relova R, Hoblyn J, Lee T, Stasio C, Mahncke H, Drag L, Grimm D, Gill S, Saini G, Relova R, Hoblyn J, Lee T, Stasio C, Mahncke H, Drag L, Verbiest R, Ringdahl E, Thaler N, Sutton G, Vogel S, Reyes A, Ringdahl E, Vogel S, Freeman A, Call E, Allen D, March E, Salzberg M, Vogel S, Ringdahl E, Freeman A, Dadis F, Allen D, Sisk S, Ringdahl E, Vogel S, Freeman A, Allen D, DiGangi J, Silva L, Pliskin N, Thieme B, Daniel M, Jaehnert S, Noggle C, Thompson J, Kecala N, Lane E, Kane C, Noggle C, Thompson J, Lane E, Kecala N, Kane C, Palmer G, Happe M, Paxson J, Jurek B, Graca J, Olson S, Melville T, Harley A, La D, Phoong M, Gill S, Jocson VA, Nunan-Saah J, Keller J, Gomez R, Melville T, Kaminetskaya M, Poole J, Vernon A, Van Vleet T, DeGutis J, Chen A, Marini C, Dabit S, Gallegos J, Zomet A, Merzenich M, Thaler N, Linck J, Heyanka D, Pastorek N, Miller B, Romesser J, Sim A, Allen D, Zimmer A, Marcinak J, Hibyan S, Webbe F, Rainwater B, Francis J, Baum L, Sautter S, Donders J, Hui E, Barnes K, Walls G, Erikson S, Bailie J, Schwab K, Ivins B, Boyd C, Neff J, Cole W, Lewis S, Bailie J, Schwab K, Ivins B, Boyd C, Neff J, Cole W, Lewis S, Ramirez C, Oganes M, Gold S, Tanner S, Pina D, Merritt V, Arnett P, Heyanka D, Linck J, Thaler N, Pastorek N, Miller B, Romesser J, Sim A, Parks A, Roskos P, Gfeller J, Clark A, Isham K, Carter J, McLeod J, Romero R, Dahdah M, Barisa M, Schmidt K, Barnes S, Dubiel R, Dunklin C, Harper C, Callender L, Wilson A, Diaz-Arrastia R, Shafi S, Jacquin K, Bolshin L, Jacquin K, Romers C, Gutierrez E, Messerly J, Tsou J, Adler M, Golden C, Harmell A, Mausbach B, Moore R, Depp C, Jeste D, Palmer B, Hoadley R, Hill B, Rohling M, Mahdavi S, Fine J, daCruz K, Dinishak D, Richardson G, Vertinski M, Allen D, Mayfield J, Margolis S, Miele A, Rabinovitz B, Schaffer S, Kline J, Boettcher A, Hill B, Hoadley R, Rohling M, Eichstaedt K, Vale F, Benbadis S, Bozorg A, Rodgers-Neame N, Rinehardt E, Mattingly M, Schoenberg M, Fares R, Fares R, Carrasco R, Grups J, Evans B, Simco E, Mittenberg W, Carrasco R, Grups J, Evans B, Simco E, Mittenberg W, Rach A, Baughman B, Young C, Bene E, Irwin C, Li Y, Poulin R, Jerram M, Susmaras T, Gansler D, Ashendorf L, Miarmi L, Fazio R, Cantor J, Fernandez A, Godoy-Garcete G, Marchetti P, Harrison A, Armstrong I, Harrison L, Iverson G, Brinckman D, Ayaz H, Schultheis M, Heinly M, Vitelli K, Russler K, Sanchez I, Jones W, Loe S, Raines T, Hart J, Bene E, Li Y, Irwin C, Baughman B, Rach A, Bravo J, Schilling B, Weiss L, Lange R, Shewchuk J, Heran M, Rauscher A, Jarrett M, Brubacher J, Iverson G, Zink D, Barney S, Gilbert G, Allen D, Martin P, Schroeder R, Klas P, Jeffay E, Zakzanis K, Iverson G, Lanting S, Saffer B, Koehle M, Palmer B, Barrio C, Vergara R, Muniz M, Pinto L, Jeste D, Stenclik J, Lynch J, McCaffrey R, Shultz LS, Pedersen H, Roper B, Crouse E, Crucian G, Dezhkam N, Mulligan K, Singer R, Psihogios A, Davis A, Stephens B, Love C, Mulligan K, Webbe F, West S, McCue R, Goldin Y, Cicerone K, Ruchinskas R, Seidl JT, Massman P, Tam J, Schmitter-Edgecombe M, Baerresen K, Hanson E, Miller K, Miller J, Yeh D, Kim J, Ercoli L, Siddarth P, Small G, Noback M, Noback M, Baldock D, Mahmoud S, Munic-Miller D, Bonner-Jackson A, Banks S, Rabin L, Emerson J, Smith C, Roberts R, Hass S, Duhig A, Pankratz V, Petersen R, Leibson C, Harley A, Melville T, Phoong M, Gill S, Nunan-Saah J, La D, Gomez R, Lindbergh C, Puente A, Gray J, Chu K, Evans S, Sweet L, MacKillop J, Miller L, McAlister C, Schmitter-Edgecombe M, Baldassarre M, Kamm J, Wolff D, Dombrowski C, Bullard S, Edwards M, Hall J, Parsons T, O'Bryant S, Lawson R, Papadakis A, Higginson C, Barnett J, Wills M, Strang J, Dominska A, Wallace G, Kenworthy L, Bott N, Kletter H, Carrion V, Ward C, Getz G, Peer J, Baum C, Edner B, Mannarino A, Casnar C, Janke K, van der Fluit F, Natalie B, Haberman D, Solomon M, Hunter S, Klein-Tasman B, Starza-Smith A, Talbot E, Hart A, Hall M, Baker J, Kral M, Lally M, Zisk A, Lo T, Ross P, Cuevas M, Patel S, Lebby P, Mouanoutoua A, Harrison J, Pollock M, Mathiowetz C, Romero R, Boys C, Vekaria P, Vasserman M, MacAllister W, Stevens S, Van Hecke A, Carson A, Karst J, Schohl K, Dolan B, McKindles R, Remel R, Reveles A, Fritz N, McDonald G, Wasisco J, Kahne J, Hertza J, Tyson K, Northington S, Loughan A, Perna R, Newman A, Garmoe W, Clark J, Loughan A, Perna R, Hertza J, Cohen M, Northington S, Tyson K, Whithers K, Puente A, Dedmon A, Capps J, Lindsey H, Francis M, Weigand L, Steed A, Puente A, Edmed S, Sullivan K, Puente A, Lindsey H, Dedmon A, Capps J, Whithers K, Weigand L, Steed A, Kark S, Lafleche G, Brown T, Bogdanova Y, Strongin E, Spickler C, Drasnin D, Strongin C, Poreh A, Houshyarnejad A, Ellis M, Babikian T, Kernan C, Asarnow R, Didehbani N, Cullum M, Loneman L, Mansinghani S, Hart J, Fischer J. POSTER SESSIONS SCHEDULE. Arch Clin Neuropsychol 2013. [DOI: 10.1093/arclin/act054] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
O'Sullivan F, Muzi M, Huang J, Eary J, Link J, Krohn K. 261 A Fully Automatic Procedure for Image Derived Blood Extraction, Including Assessment of Metabolite, in Dynamic PET Fluorothymidine (FLT) Studies. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)72059-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
41
|
Choi YJ, Gabikian P, Zhu F, Appelbaum DE, Wollmann RL, Lukas RV, Xu LW, Thomas RP, Lober RM, Nagpal S, Li G, Megyesi JF, Macdonald D, Chaudhary N, Berghoff AS, Spanberger T, Magerle M, Dinhof C, Woehrer A, Hackl M, Birner P, Widhalm G, Marosi C, Prayer D, Preusser M, Kamson DO, Juhasz C, Buth A, Kupsky WJ, Muzik O, Robinette NL, Barger GR, Mittal S, Kinoshita M, Hirayama R, Chiba Y, Kagawa N, Nonaka M, Kanemura Y, Kishima H, Nakajima S, Hatazawa J, Hashimoto N, Yoshimine T, Kim EH, Kim SH, Nowosielski M, Hutterer M, Putzer D, Iglseder S, Seiz M, Jacobs AH, Gobel G, Stockhammer G, Hutterer M, Nowosielski M, Putzer D, Iglseder S, Seiz M, Jacobs AH, Gobel G, Stockhammer G, Juhasz C, Buth A, Kamson DO, Kupsky WJ, Barger GR, Mittal S, Zach L, Guez D, Last D, Daniels D, Grober Y, Nissim O, Hoffman C, Nass D, Spiegelmann R, Cohen ZR, Mardor Y, Mittal S, Buth A, Kupsky WJ, Kamson DO, Barger GR, Juhasz C, Perreault S, Lober RM, Zhang GH, Hershon L, Decarie JC, Yeom K, Vogel H, Partap S, Carret AS, Fisher PG, Colen RR, Changlai T, Sathyan P, Gutman D, Zinn P, Colen RR, Kovacs A, Zinn P, Jolesz F, Colen RR, Zinn P, Asthagiri A, Vasquez R, Butman J, Wu T, Morgan K, Brewer C, King K, Zalewski C, Jeffrey Kim H, Lonser R, Akbari H, Da X, Macyszyn L, Verma R, Wolf RL, Bilello M, Melhem ER, O'Rourke DM, Davatzikos C, Liu X, Madhankumar AB, Miller PA, Duck KA, Hafenstein S, Rizk E, Sheehan JM, Connor JR, Yang QX, Fouke SJ, Weinberger K, Kelsey M, Cholleti S, Politte D, Marcus D, Boyd A, Keogh B, Benzinger T, Milchenko M, Kim L, Prior F, Kim LM, Commean P, Boyd A, Milchenko M, Politte D, Chicoine M, Rich K, Benzinger T, Marcus D, Jost S, Fatterpekar G, Raz E, Knopp E, Gruber M, Parker E, Golfinos J, Zagzag D, Parker E, Fatterpekar G, Raz E, Narayana A, Johnson G, Placantonakis D, Zagzag D, Wen Q, Essock-Burns E, Li Y, Chang S, Nelson SJ, Li Y, Larson P, Chen A, Lupo JM, Kelley D, Chang S, Nelson SJ, Li Y, Lupo JM, Parvataneni R, Lamborn K, Cha S, Chang S, Nelson SJ, Jalbert LE, Elkhaled A, Phillips JJ, Williams C, Cha S, Berger MS, Chang SM, Nelson SJ, Damek DM, Ney DE, Borges MT, Colantoni W, Bert R, Huang R, Chen C, Mukundan S, Wen P, Norden A, Andre JB, Schmiedeskamp H, Thomas RP, Feroze A, Nagpal S, Zaharchuk G, Straka M, Recht L, Bammer R, Rockhill J, Mrugala M, Fink J, Rostomily R, Link J, Muzi M, Eary J, Krohn K, Perreault S, Lober RM, Partap S, Carret AS, Fisher FG, Ellingson BM, Pope WB, Boxerman JL, Harris RJ, Lai A, Nghiemphu PL, Jeyapalan S, Safran H, Kruse CA, Liau LM, Cloughesy TF, Harris RJ, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB, Ellingson BM, Elkhaled A, Phillips J, Chang SM, Cha S, Nelson SJ. CLIN-RADIOLOGY. Neuro Oncol 2012; 14:vi120-vi128. [PMCID: PMC3488790 DOI: 10.1093/neuonc/nos236] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2023] Open
|
42
|
Valluru R, Link J, Claupein W. Consequences of early chilling stress in two Triticum species: plastic responses and adaptive significance. Plant Biol (Stuttg) 2012; 14:641-51. [PMID: 22309058 DOI: 10.1111/j.1438-8677.2011.00540.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
Phenotypic plasticity of two primitive wheat species (Triticum monococcum L. and Triticum dicoccum S.) was studied in response to early chilling stress. Selection pressure differentials, gradients and plasticity costs on plant morphogenesis, growth and reserve carbohydrate consumption were estimated. Regression analysis was applied to investigate differential developmental changes and patterns between treatments. Four-day-old seedlings of T. monococcum and T. dicoccum, differing in plant stature and reserve carbohydrates, were given an early chilling temperature (4 °C for 42 day) and compared with control plants grown at 23 °C. Early chilling stress resulted in a significant increase in leaf mass ratio (LMR) and relative growth rate (RGR), a reduction in flag leaf size, total biomass, specific leaf area (SLA) and reserve carbohydrate storage at flowering, together with advanced onset of flowering. Selection pressure within the early chilling environment favoured early flowering, smaller SLA, higher LMR and lower reserve carbohydrates, suggesting the observed responses were adaptive. Furthermore, a regression of daily cumulative plant biomass derived from a crop growth simulation model (CERES-Wheat) on crop vegetation period revealed a divergent developmental pattern in early-chilled plants. Using selection pressure gradient analysis, we found similar responses among these traits, except for SLA and sucrose, indicating that these two traits have indirect effects on fitness. Thus, the total effects of SLA and reserve sucrose on relative fitness seem to be buffered via the rapid growth rate in chilled plants. While lower SLA may reduce early chilling stress effects at an individual leaf level, a higher LMR and use of reserve carbohydrates indicated that compensatory growth of chilled plants during the recovery period relied on the concerted action of altered resource allocation and reserve carbohydrate consumption. However, a significant cost of plasticity was evident only for flowering time, LMR and fructan levels in the early chilling environment. Our results demonstrate that morphological and intrinsic developmental (ontogenetic) patterns in two Triticum species respond to early chilling stress.
Collapse
Affiliation(s)
- R Valluru
- Institute of Crop Science, University of Hohenheim, Stuttgart, Germany.
| | | | | |
Collapse
|
43
|
Fink K, Lundkvist M, Link J, Kockum I, Hermanrud C, Brynedal B, Hillert J, Fogdell-Hahn A. Investigation of the Effect of Human Leukocyte Antigen on the Development of Neutralizing Antibodies in Interferon-beta Treated Patients with Multiple Sclerosis (*The First Three Authors Contributed Equally to This Work) (P05.121). Neurology 2012. [DOI: 10.1212/wnl.78.1_meetingabstracts.p05.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
44
|
Mankoff DA, Linden HM, Link J, Kurland BF, Schubert EK, Peterson L, Gadi VK, Specht JM, Shankar L, Eary JF. NCI-sponsored phase II study of [18f]fluoroestradiol (FES) as a marker of hormone sensitivity of metastatic breast cancer: Initial results. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e11104] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
45
|
Byron C, Link J, Costa-Pierce B, Bengtson D. Calculating ecological carrying capacity of shellfish aquaculture using mass-balance modeling: Narragansett Bay, Rhode Island. Ecol Modell 2011. [DOI: 10.1016/j.ecolmodel.2011.03.010] [Citation(s) in RCA: 87] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
46
|
Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, Harbo HF, Padyukov L, Alfredsson L, Olsson T, Sadovnick AD, Hillert J, Ebers GC. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 2009; 73:2107-11. [DOI: 10.1212/wnl.0b013e3181c679f3] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
47
|
Capri G, Chang J, Chen SC, Conte P, Cwiertka K, Jerusalem G, Jiang Z, Johnston S, Kaufman B, Link J, Ro J, Schütte J, Oliva C, Parikh R, Preston A, Rosenlund J, Selzer M, Zembryki D, De Placido S. An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer. Ann Oncol 2009; 21:474-480. [PMID: 19815649 DOI: 10.1093/annonc/mdp373] [Citation(s) in RCA: 65] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND The Lapatinib Expanded Access Program (LEAP) was designed to provide access to lapatinib plus capecitabine for HER2-positive metastatic breast cancer patients who previously received an anthracycline, a taxane, and a trastuzumab and had no other treatment options. PATIENTS AND METHODS LEAP opened globally and enrollment continued until lapatinib received regulatory approval in each participating country. Patients were assessed for progression-free survival (PFS) and overall survival (OS) and monitored for serious adverse events (SAEs). RESULTS As of 30 September 2008, 4283 patients from 45 countries enrolled in LEAP. The median treatment duration was 24.7 weeks. The most common drug-related SAEs were diarrhea (9.7%), vomiting (4.3%), and nausea (2.4%) and were mainly grade 3 or higher. The incidences of special interest SAEs were decreased left ventricle ejection fraction (0.5%), interstitial lung disease/pneumonitis (0.2%), and serious hepatobiliary events (0.4%). This safety profile is consistent with the overall lapatinib program. The median PFS and OS were 21.1 [95% confidence interval (CI) = 20.1-22.3] and 39.6 (95% CI = 37.7-40.7) weeks, respectively (n = 4006). Subgroup analysis showed longer PFS and OS in patients who had not received prior capecitabine. CONCLUSIONS These results demonstrate the safety and efficacy of lapatinib in a broader patient population compared with a clinical trial.
Collapse
Affiliation(s)
- G Capri
- Department of Medical Oncology, Fondazione IRCCS Istituto Tumori, Milano, Italy.
| | - J Chang
- Medical Oncology Program, RS McLaughlin Durham Regional Cancer Centre, Oshawa, Ontario, Canada
| | - S-C Chen
- Department of General Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan
| | - P Conte
- Department of Oncology and Hematology, Universita degli Studi di Modena e Reggio Emilia, Modena, Italy
| | - K Cwiertka
- Department of Oncology, Hospital Olomouc, Olomouc, Czech Republic
| | - G Jerusalem
- Department of Medical Oncology, CHU Liège Hospital du Sart-Tilman, Liège, Belgium
| | - Z Jiang
- Breast Cancer Department, The Hospital Associated With Military Medical Science, Beijing, China
| | - S Johnston
- Department of Medical Oncology, Royal Marsden NHS Foundation Trust & Institute of Cancer Research, London, UK
| | - B Kaufman
- Breast Cancer Unit, Sheba Medical Center, Ramat Gan, Israel
| | - J Link
- Breast Link Medical Group, Inc., Long Beach, CA, USA
| | - J Ro
- Breast and Endocrine Cancer Branch, National Cancer Center, Kyunggi-do, South Korea
| | - J Schütte
- Department of Hematology and Oncology, Marien Hospital Düsseldorf, Düsseldorf, Germany
| | - C Oliva
- Oncology Medicine Development Center, GlaxoSmithKline, Uxbridge, Middlesex, UK
| | - R Parikh
- Oncology Medicine Development Center, GlaxoSmithKline, Uxbridge, Middlesex, UK
| | - A Preston
- Oncology Medicine Development Center, GlaxoSmithKline, Collegeville, PA, USA
| | - J Rosenlund
- Oncology Medicine Development Center, GlaxoSmithKline, Collegeville, PA, USA
| | - M Selzer
- Oncology, Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Collegeville, PA, USA
| | - D Zembryki
- Oncology Medicine Development Center, GlaxoSmithKline, Collegeville, PA, USA
| | - S De Placido
- Department of Molecular and Clinical Oncology, Universita degli Studi di Napoli Federico II, Napoli, Italy
| |
Collapse
|
48
|
Overholtz W, Link J. A simulation model to explore the response of the Gulf of Maine food web to large-scale environmental and ecological changes. Ecol Modell 2009. [DOI: 10.1016/j.ecolmodel.2009.06.034] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
49
|
Link J, Pachaly J. Intranarkotische Infusionstherapie – Eine Computerauswertung mit dem Programmpaket SPSS (Statistical Package for the Social Sciences). Transfus Med Hemother 2009. [DOI: 10.1159/000219628] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
50
|
Link J, Col L, Guida V, Dow D, O’Reilly J, Green J, Overholtz W, Palka D, Legault C, Vitaliano J, Griswold C, Fogarty M, Friedland K. Response of balanced network models to large-scale perturbation: Implications for evaluating the role of small pelagics in the Gulf of Maine. Ecol Modell 2009. [DOI: 10.1016/j.ecolmodel.2008.10.009] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|